The	O
proteasome	B-protein
regulates	O
receptor-mediated	O
endocytosis	O
of	O
interleukin-2	B-protein
.	O

Recent	O
studies	O
have	O
increasingly	O
implicated	O
the	O
proteasome	B-protein
in	O
the	O
regulation	O
of	O
cell	B-protein
surface	I-protein
receptors	I-protein
.	O

In	O
the	O
present	O
study	O
,	O
we	O
investigated	O
the	O
role	O
of	O
the	O
proteasome	B-protein
for	O
ligand-dependent	O
endocytosis	O
and	O
degradation	O
of	O
the	O
interleukin-2	B-protein
(	I-protein
IL-2	I-protein
)	I-protein
-interleukin-2	I-protein
receptor	I-protein
(	I-protein
IL-2R	I-protein
)	I-protein
complex	I-protein
.	O

Proteasome	O
inhibitors	O
impaired	O
internalization	O
of	O
IL-2.IL-2R	B-protein
and	O
prevented	O
the	O
lysosomal	O
degradation	O
of	O
this	O
cytokine	B-protein
.	O

Based	O
on	O
time-course	O
studies	O
,	O
proteasome	B-protein
activity	O
is	O
primarily	O
required	O
after	O
initial	O
endocytosis	O
of	O
the	O
IL-2.IL-2R	B-protein
.	O

Proteasome	O
function	O
was	O
also	O
necessary	O
for	O
the	O
lysosomal	O
degradation	O
of	O
IL-2	B-protein
internalized	O
by	O
IL-2R	B-protein
that	O
were	O
comprised	O
of	O
cytoplasmic	B-protein
tailless	I-protein
beta-	B-protein
or	I-protein
gamma	I-protein
c-subunits	I-protein
,	O
suggesting	O
that	O
the	O
target	O
protein	O
for	O
the	O
proteasome	B-protein
is	O
independent	O
of	O
either	O
the	O
cytoplasmic	B-protein
tail	I-protein
of	O
the	O
IL-2R	B-protein
beta-	B-protein
or	I-protein
gamma	I-protein
c-subunits	I-protein
and	O
their	O
associated	O
signaling	O
components	O
.	O

Therefore	O
,	O
a	O
functional	O
proteasome	B-protein
is	O
required	O
for	O
optimal	O
endocytosis	O
of	O
the	O
IL-2R/ligand	B-protein
complex	I-protein
and	O
is	O
essential	O
for	O
the	O
subsequent	O
lysosomal	O
degradation	O
of	O
IL-2	B-protein
,	O
possibly	O
by	O
regulating	O
trafficking	O
to	O
the	O
lysosome	O
.	O

THE	NULL
JOURNAL	NULL
oF	NULL
BIOLOGICAL	NULL
CHEMISTRY	NULL
©	NULL
2001	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
for	NULL
Biochemistry	NULL
and	NULL
Molecular	NULL
Biology	NULL
,	NULL
Inc.	NULL
Vol	NULL
.	NULL

276	NULL
,	NULL
No	NULL
.	NULL

1	NULL
,	NULL
Issue	NULL
of	NULL
January	NULL
5	NULL
,	NULL
pp	NULL
.	NULL

381-385	NULL
,	NULL
2001	NULL
Printed	NULL
in	NULL
U.S.A	NULL
.	NULL

The	NULL
Proteasome	NULL
Regulates	NULL
Receptor-mediated	NULL
Endocytosis	NULL
of	NULL
Interleukin-2*	NULL
Received	NULL
for	NULL
publication	NULL
,	NULL
August	NULL
31	NULL
,	NULL
2000	NULL
,	NULL
and	NULL
in	NULL
revised	NULL
form	NULL
,	NULL
October	NULL
10	NULL
,	NULL
2000	NULL
Published	NULL
,	NULL
JBC	NULL
Papers	NULL
in	NULL
Press	NULL
,	NULL
October	NULL
13	NULL
,	NULL
2000	NULL
,	NULL
DOI	NULL
10.1074/jbc.MO07991200	NULL
Aixin	NULL
Yu	NULL
and	NULL
Thomas	NULL
R.	NULL
Malek	NULL
$	NULL
From	NULL
the	NULL
Department	NULL
of	NULL
Microbiology	NULL
and	NULL
Immunology	NULL
,	NULL
University	NULL
of	NULL
Miami	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
Miami	NULL
,	NULL
Florida	NULL
33136	NULL
Recent	NULL
studies	NULL
have	NULL
increasingly	NULL
implicated	NULL
the	NULL
proteasome	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
cell	NULL
surface	NULL
receptors	NULL
.	NULL

In	NULL
the	NULL
present	NULL
study	NULL
,	NULL
we	NULL
investigated	NULL
the	NULL
role	NULL
of	NULL
the	NULL
proteasome	NULL
for	NULL
ligand-dependent	NULL
endocytosis	NULL
and	NULL
degradation	NULL
of	NULL
the	NULL
interleukin-2	NULL
(	NULL
IL-2	NULL
)	NULL
-interleukin-2	NULL
receptor	NULL
(	NULL
IL-2R	NULL
)	NULL
complex	NULL
.	NULL

Proteasome	NULL
inhibitors	NULL
impaired	NULL
internalization	NULL
of	NULL
IL-2IL-2R	NULL
and	NULL
prevented	NULL
the	NULL
lysosomal	NULL
degradation	NULL
of	NULL
this	NULL
cytokine	NULL
.	NULL

Based	NULL
on	NULL
time-course	NULL
stud-ies	NULL
,	NULL
proteasome	NULL
activity	NULL
is	NULL
primarily	NULL
required	NULL
after	NULL
initial	NULL
endocytosis	NULL
of	NULL
the	NULL
IL-2IL-2R	NULL
.	NULL

Proteasome	NULL
function	NULL
was	NULL
also	NULL
necessary	NULL
for	NULL
the	NULL
lysosomal	NULL
degradation	NULL
of	NULL
IL-2	NULL
internalized	NULL
by	NULL
IL-2R	NULL
that	NULL
were	NULL
comprised	NULL
of	NULL
cytoplasmic	NULL
tailless	NULL
B-	NULL
or	NULL
ye-subunits	NULL
,	NULL
suggesting	NULL
that	NULL
the	NULL
target	NULL
protein	NULL
for	NULL
the	NULL
proteasome	NULL
is	NULL
independent	NULL
of	NULL
either	NULL
the	NULL
cytoplasmic	NULL
tail	NULL
of	NULL
the	NULL
IL-2R	NULL
B-	NULL
or	NULL
ye-subunits	NULL
and	NULL
their	NULL
associated	NULL
signaling	NULL
components	NULL
.	NULL

Therefore	NULL
,	NULL
a	NULL
functional	NULL
proteasome	NULL
is	NULL
required	NULL
for	NULL
optimal	NULL
endocytosis	NULL
of	NULL
the	NULL
IL-2R/ligand	NULL
complex	NULL
and	NULL
is	NULL
essential	NULL
for	NULL
the	NULL
subsequent	NULL
lysosomal	NULL
degradation	NULL
of	NULL
IL-2	NULL
,	NULL
possibly	NULL
by	NULL
regulating	NULL
trafficking	NULL
to	NULL
the	NULL
lysosome	NULL
.	NULL

The	NULL
high	NULL
affinity	NULL
interleukin-2	NULL
receptor	NULL
(	NULL
IL-2R	NULL
)	NULL
'	NULL
is	NULL
comprised	NULL
of	NULL
three	NULL
subunits	NULL
;	NULL
an	NULL
«	NULL
-chain	NULL
,	NULL
which	NULL
functions	NULL
solely	NULL
in	NULL
IL-2	NULL
binding	NULL
,	NULL
and	NULL
B-	NULL
and	NULL
common	NULL
y	NULL
(	NULL
yc	NULL
)	NULL
-chains	NULL
that	NULL
function	NULL
in	NULL
both	NULL
ligand	NULL
binding	NULL
and	NULL
signal	NULL
transduction	NULL
(	NULL
1	NULL
)	NULL
.	NULL

IL-2	NULL
promotes	NULL
oligomerization	NULL
of	NULL
these	NULL
subunits	NULL
and	NULL
activation	NULL
of	NULL
a	NULL
number	NULL
of	NULL
receptor-associated	NULL
signaling	NULL
molecules	NULL
,	NULL
including	NULL
Janus	NULL
kinase	NULL
(	NULL
Jak	NULL
)	NULL
-1/3	NULL
,	NULL
signal	NULL
transducer	NULL
and	NULL
activator	NULL
of	NULL
transcription	NULL
(	NULL
STAT	NULL
)	NULL
5/3	NULL
,	NULL
p56lck	NULL
,	NULL
and	NULL
phosphatidylinositol-3-kinase	NULL
that	NULL
is	NULL
recruited	NULL
by	NULL
the	NULL
Shc-adapter	NULL
protein	NULL
(	NULL
2	NULL
)	NULL
.	NULL

Another	NULL
immediate	NULL
consequence	NULL
of	NULL
IL-2-IL-2R	NULL
interaction	NULL
is	NULL
ligand-induced	NULL
receptor-mediated	NULL
endocytosis	NULL
of	NULL
the	NULL
receptor-ligand	NULL
complex	NULL
.	NULL

In	NULL
T	NULL
lymphocytes	NULL
,	NULL
50	NULL
%	NULL
of	NULL
the	NULL
receptor-ligand	NULL
complex	NULL
is	NULL
internalized	NULL
within	NULL
10-15	NULL
min	NULL
(	NULL
3	NULL
,	NULL
4	NULL
)	NULL
.	NULL

Ligand-induced	NULL
endocytosis	NULL
of	NULL
the	NULL
IL-2R	NULL
is	NULL
primarily	NULL
dependent	NULL
upon	NULL
the	NULL
cytoplasmic	NULL
tail	NULL
of	NULL
yc	NULL
(	NULL
5	NULL
,	NULL
6	NULL
)	NULL
.	NULL

Studies	NULL
that	NULL
have	NULL
followed	NULL
the	NULL
fate	NULL
of	NULL
these	NULL
proteins	NULL
indicate	NULL
that	NULL
IL-2Ra	NULL
recycles	NULL
to	NULL
the	NULL
plasma	NULL
membrane	NULL
from	NULL
an	NULL
early	NULL
endosomal	NULL
compartment	NULL
,	NULL
whereas	NULL
the	NULL
B-	NULL
and	NULL
ye-subunits	NULL
as	NULL
well	NULL
as	NULL
IL-2	NULL
traffic	NULL
to	NULL
the	NULL
lysosome	NULL
,	NULL
where	NULL
they	NULL
are	NULL
degraded	NULL
(	NULL
7	NULL
)	NULL
.	NULL

*	NULL
This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
Grant	NULL
AT40114	NULL
.	NULL

The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
1784	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

J	NULL
To	NULL
whom	NULL
correspondence	NULL
should	NULL
be	NULL
addressed	NULL
:	NULL
Dept	NULL
.	NULL

of	NULL
Microbiology	NULL
and	NULL
Immunology	NULL
,	NULL
University	NULL
of	NULL
Miami	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
1600	NULL
NW	NULL
10th	NULL
Ave.	NULL
,	NULL
Miami	NULL
,	NULL
FL	NULL
88186	NULL
.	NULL

Tel	NULL
.	NULL

:	NULL
805-248-5627	NULL
;	NULL
Fax	NULL
:	NULL
805-248-4628	NULL
;	NULL
Email	NULL
:	NULL
tmalek	NULL
@	NULL
med.miami.edu	NULL
.	NULL

*	NULL
The	NULL
abbreviations	NULL
used	NULL
are	NULL
:	NULL
IL-2R	NULL
,	NULL
interleukin-2	NULL
receptor	NULL
;	NULL
Me,50	NULL
,	NULL
dimethyl	NULL
sulfoxide	NULL
;	NULL
yc	NULL
,	NULL
common	NULL
y-chain	NULL
;	NULL
I	NULL
,	NULL
intracellular	NULL
;	NULL
IL-2	NULL
,	NULL
interleu-kin-2	NULL
;	NULL
Jak	NULL
,	NULL
Janus	NULL
kinase	NULL
;	NULL
PBS	NULL
,	NULL
phosphate-buffered	NULL
saline	NULL
;	NULL
S	NULL
,	NULL
surface	NULL
;	NULL
STAT	NULL
,	NULL
signal	NULL
transducer	NULL
and	NULL
activator	NULL
of	NULL
transcription	NULL
;	NULL
cpm	NULL
,	NULL
counts/	NULL
min	NULL
;	NULL
PSI	NULL
,	NULL
peptide	NULL
aldehyde	NULL
proteasome	NULL
inhibitor	NULL
.	NULL

Within	NULL
the	NULL
immune	NULL
system	NULL
,	NULL
the	NULL
proteasome	NULL
is	NULL
essential	NULL
for	NULL
production	NULL
of	NULL
peptides	NULL
for	NULL
MHC	NULL
class	NULL
I	NULL
antigen	NULL
presentation	NULL
.	NULL

The	NULL
proteasome	NULL
also	NULL
has	NULL
a	NULL
well	NULL
described	NULL
role	NULL
in	NULL
the	NULL
degradation	NULL
of	NULL
cytosolic	NULL
and	NULL
nuclear	NULL
proteins	NULL
,	NULL
including	NULL
the	NULL
elimination	NULL
of	NULL
misfolded	NULL
proteins	NULL
as	NULL
well	NULL
as	NULL
controlling	NULL
the	NULL
levels	NULL
of	NULL
certain	NULL
transcription	NULL
factors	NULL
or	NULL
cell	NULL
cycle	NULL
regulatory	NULL
proteins	NULL
(	NULL
8	NULL
)	NULL
.	NULL

Most	NULL
proteins	NULL
destined	NULL
for	NULL
degradation	NULL
are	NULL
targeted	NULL
to	NULL
the	NULL
proteasome	NULL
by	NULL
ubiquitination	NULL
(	NULL
9	NULL
)	NULL
.	NULL

More	NULL
recent	NULL
studies	NULL
have	NULL
implicated	NULL
ubiquitination	NULL
in	NULL
the	NULL
internalization	NULL
of	NULL
a	NULL
growing	NULL
list	NULL
of	NULL
cells	NULL
surface	NULL
receptors	NULL
(	NULL
10	NULL
,	NULL
11	NULL
)	NULL
,	NULL
suggesting	NULL
a	NULL
possible	NULL
role	NULL
for	NULL
the	NULL
proteasome	NULL
in	NULL
regulating	NULL
the	NULL
levels	NULL
of	NULL
cell	NULL
surface	NULL
receptors	NULL
.	NULL

In	NULL
the	NULL
present	NULL
study	NULL
we	NULL
have	NULL
used	NULL
specific	NULL
inhibitors	NULL
to	NULL
explore	NULL
the	NULL
potential	NULL
role	NULL
of	NULL
the	NULL
proteasome	NULL
for	NULL
endocytosis	NULL
and	NULL
degradation	NULL
of	NULL
the	NULL
complex	NULL
.	NULL

EXPERIMENTAL	NULL
PROCEDURES	NULL
Cells	NULL
and	NULL
Reagents-1FlyecWT	NULL
(	NULL
6	NULL
)	NULL
,	NULL
1F1yc284	NULL
(	NULL
12	NULL
)	NULL
,	NULL
and	NULL
CXBt	NULL
(	NULL
18	NULL
)	NULL
have	NULL
been	NULL
described	NULL
previously	NULL
.	NULL

Activated	NULL
T	NULL
cells	NULL
were	NULL
prepared	NULL
by	NULL
the	NULL
culture	NULL
of	NULL
C57BI/6	NULL
spleen	NULL
cells	NULL
with	NULL
anti-CD3	NULL
for	NULL
48	NULL
h	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
14	NULL
)	NULL
.	NULL

E-64	NULL
,	NULL
MG132	NULL
,	NULL
PSI	NULL
,	NULL
and	NULL
antipain	NULL
were	NULL
obtained	NULL
from	NULL
Peptide	NULL
International	NULL
,	NULL
Inc.	NULL
(	NULL
Louisville	NULL
,	NULL
KY	NULL
)	NULL
,	NULL
lactacystin	NULL
from	NULL
Calbio-chem-Novabiochem	NULL
Corp.	NULL
(	NULL
San	NULL
Diego	NULL
,	NULL
CA	NULL
)	NULL
,	NULL
and	NULL
chloroquine	NULL
from	NULL
Sigma	NULL
(	NULL
St.	NULL
Louis	NULL
,	NULL
MO	NULL
)	NULL
Internalization	NULL
Assay-Cells	NULL
(	NULL
10	NULL
X	NULL
10°/ml	NULL
)	NULL
were	NULL
incubated	NULL
in	NULL
RPMI	NULL
1640	NULL
containing	NULL
5	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
(	NULL
14	NULL
)	NULL
(	NULL
complete	NULL
medium	NULL
)	NULL
at	NULL
4	NULL
°C	NULL
for	NULL
30	NULL
min	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
50,000	NULL
cpm/ml	NULL
human	NULL
IL-2	NULL
(	NULL
specific	NULL
activity	NULL
~20-40	NULL
uCi/ug	NULL
)	NULL
that	NULL
was	NULL
radiolabeled	NULL
with	NULL
Na	NULL
'	NULL
``	NULL
!	NULL

using	NULL
Iodo-gen	NULL
precoated	NULL
tubes	NULL
(	NULL
Pierce	NULL
Chemical	NULL
Co.	NULL
,	NULL
Rockford	NULL
,	NULL
IL	NULL
)	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
instruction	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
then	NULL
washed	NULL
three	NULL
times	NULL
with	NULL
cold	NULL
Hank	NULL
's	NULL
balanced	NULL
salt	NULL
solution	NULL
.	NULL

Unless	NULL
otherwise	NULL
indicated	NULL
,	NULL
all	NULL
inhibitors	NULL
were	NULL
added	NULL
at	NULL
50	NULL
uM	NULL
final	NULL
concentration	NULL
to	NULL
the	NULL
cells	NULL
just	NULL
after	NULL
these	NULL
washes	NULL
.	NULL

In	NULL
the	NULL
case	NULL
of	NULL
lactacystin	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
also	NULL
cultured	NULL
with	NULL
this	NULL
proteasome	NULL
inhibitor	NULL
for	NULL
2	NULL
h	NULL
in	NULL
complete	NULL
medium	NULL
and	NULL
cooled	NULL
on	NULL
ice	NULL
for	NULL
15	NULL
min	NULL
prior	NULL
to	NULL
treatment	NULL
with	NULL
'*I-labeled	NULL
IL-2	NULL
.	NULL

Dimethyl	NULL
sulfoxide	NULL
(	NULL
Me	NULL
,	NULL
S80	NULL
)	NULL
,	NULL
which	NULL
was	NULL
the	NULL
solvent	NULL
for	NULL
all	NULL
the	NULL
proteasome	NULL
inhibitors	NULL
,	NULL
was	NULL
added	NULL
to	NULL
the	NULL
control	NULL
cells	NULL
at	NULL
a	NULL
concentration	NULL
of	NULL
<	NULL
1	NULL
%	NULL
.	NULL

The	NULL
IL-2-pulsed	NULL
cells	NULL
(	NULL
4	NULL
X	NULL
10°/ml	NULL
)	NULL
were	NULL
then	NULL
cultured	NULL
in	NULL
complete	NULL
medium	NULL
at	NULL
37°C	NULL
using	NULL
a	NULL
water	NULL
bath	NULL
in	NULL
1	NULL
ml	NULL
of	NULL
medium/tube	NULL
using	NULL
1.5-ml	NULL
microcentrifuge	NULL
tubes	NULL
.	NULL

At	NULL
the	NULL
indicated	NULL
times	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
pelleted	NULL
by	NULL
centrifugation	NULL
in	NULL
a	NULL
microcentrifuge	NULL
at	NULL
14,000	NULL
X	NULL
g	NULL
for	NULL
15	NULL
s.	NULL
Protein	NULL
released	NULL
in	NULL
the	NULL
supernatant	NULL
was	NULL
precipitated	NULL
by	NULL
addition	NULL
of	NULL
one-fourth	NULL
volume	NULL
of	NULL
50	NULL
%	NULL
trichloroacetic	NULL
acid	NULL
.	NULL

The	NULL
trichloroacetic	NULL
acid	NULL
soluble	NULL
counts	NULL
represented	NULL
internalized	NULL
IL-2	NULL
that	NULL
was	NULL
degraded	NULL
.	NULL

The	NULL
cell	NULL
pellets	NULL
were	NULL
then	NULL
resuspended	NULL
in	NULL
0.5	NULL
ml	NULL
of	NULL
0.01	NULL
M	NULL
sodium	NULL
citrate	NULL
,	NULL
0.14	NULL
M	NULL
NaCl	NULL
,	NULL
pH	NULL
2	NULL
buffer	NULL
for	NULL
2	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
and	NULL
centrifuged	NULL
for	NULL
15	NULL
s	NULL
at	NULL
14,000	NULL
x	NULL
g	NULL
in	NULL
a	NULL
microcentrifuge	NULL
.	NULL

The	NULL
radioactivity	NULL
that	NULL
remained	NULL
associated	NULL
with	NULL
the	NULL
cells	NULL
after	NULL
this	NULL
low	NULL
pH	NULL
buffer	NULL
wash	NULL
represented	NULL
the	NULL
internalized	NULL
(	NULL
/	NULL
)	NULL
IL-2	NULL
whereas	NULL
the	NULL
portion	NULL
of	NULL
radioactivity	NULL
in	NULL
the	NULL
pH	NULL
2	NULL
buffer	NULL
supernatant	NULL
represented	NULL
cell	NULL
surface-associated	NULL
(	NULL
S	NULL
)	NULL
IL-2	NULL
.	NULL

Before	NULL
shifting	NULL
the	NULL
cells	NULL
to	NULL
37	NULL
°C	NULL
,	NULL
usually	NULL
75-85	NULL
%	NULL
of	NULL
the	NULL
cpm	NULL
was	NULL
cell-surface	NULL
associated	NULL
.	NULL

The	NULL
I/S	NULL
ratio	NULL
was	NULL
calculated	NULL
at	NULL
the	NULL
indicated	NULL
time	NULL
points	NULL
.	NULL

The	NULL
pH	NULL
2-resistant	NULL
material	NULL
at	NULL
time	NULL
0	NULL
(	NULL
¢	NULL
,	NULL
)	NULL
was	NULL
considered	NULL
nonspecific	NULL
material	NULL
and	NULL
was	NULL
subtracted	NULL
from	NULL
I	NULL
.	NULL

Western	NULL
Blot	NULL
Analysis-1F1ycWT	NULL
cells	NULL
were	NULL
extracted	NULL
in	NULL
buffer	NULL
containing	NULL
0.5	NULL
%	NULL
Nonidet	NULL
P-40	NULL
,	NULL
phenylmethylsulfonyl	NULL
fluoride	NULL
(	NULL
1	NULL
mM	NULL
)	NULL
,	NULL
leu-peptin	NULL
(	NULL
10	NULL
ug/ml	NULL
)	NULL
,	NULL
aprotinin	NULL
(	NULL
10	NULL
ug/m	NULL
!	NULL

1	NULL
)	NULL
,	NULL
iodoacetamide	NULL
(	NULL
10	NULL
mM	NULL
)	NULL
,	NULL
sodium	NULL
orthovanadate	NULL
(	NULL
1	NULL
mM	NULL
)	NULL
,	NULL
and	NULL
sodium	NULL
fluoride	NULL
(	NULL
1	NULL
mM	NULL
)	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
15	NULL
)	NULL
and	NULL
precipitated	NULL
with	NULL
anti-STATS5	NULL
antibodies	NULL
(	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
,	NULL
Inc.	NULL
,	NULL
Santa	NULL
Cruz	NULL
,	NULL
CA	NULL
)	NULL
associated	NULL
to	NULL
protein	NULL
G-Sepharose	NULL
.	NULL

This	NULL
paper	NULL
is	NULL
available	NULL
on	NULL
line	NULL
at	NULL
http	NULL
:	NULL
//www.jbc.org	NULL
381	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san8	NULL
4g	NULL
/S10-aqf	NULL
/	NULL
wroj	NULL
;	NULL
382	NULL
Proteasome	NULL
and	NULL
Endocytosis	NULL
of	NULL
IL-2	NULL
A	NULL
B	NULL
C	NULL
Surface	NULL
Intracellular	NULL
Degraded	NULL
100	NULL
-=-	NULL
Control	NULL
__	NULL
100	NULL
-=-	NULL
Control	NULL
100-4	NULL
-=-	NULL
Control	NULL
-a-	NULL
MG132	NULL
-a-	NULL
MG132	NULL
--	NULL
MG132	NULL
ca	NULL
75	NULL
75	NULL
«	NULL
l	NULL
T	NULL
&	NULL
50	NULL
50	NULL
a	NULL
25	NULL
25	NULL
1	NULL
¥	NULL
I	NULL
L	NULL
U	NULL
1	NULL
U	NULL
0	NULL
30	NULL
60	NULL
90	NULL
120	NULL
150	NULL
180	NULL
t	NULL
T	NULL
T	NULL
T	NULL
T	NULL
0	NULL
30	NULL
60	NULL
90	NULL
120	NULL
150	NULL
180	NULL
0	NULL
J	NULL
1	NULL
I	NULL
1	NULL
U	NULL
0	NULL
30	NULL
60	NULL
90	NULL
120	NULL
150	NULL
180	NULL
Time	NULL
(	NULL
min	NULL
)	NULL
Fic	NULL
.	NULL

1	NULL
.	NULL

Effect	NULL
of	NULL
a	NULL
proteasome	NULL
inhibitor	NULL
on	NULL
receptor-mediated	NULL
endocytosis	NULL
of	NULL
IL-2	NULL
.	NULL

1F1ycWT	NULL
cells	NULL
were	NULL
pulsed	NULL
with	NULL
IL-2	NULL
,	NULL
treated	NULL
with	NULL
MG132	NULL
(	NULL
50	NULL
pM	NULL
)	NULL
,	NULL
and	NULL
cultured	NULL
for	NULL
3	NULL
h	NULL
at	NULL
37	NULL
°C	NULL
.	NULL

At	NULL
the	NULL
indicated	NULL
time	NULL
,	NULL
the	NULL
fraction	NULL
of	NULL
IL-2	NULL
that	NULL
was	NULL
on	NULL
the	NULL
cell	NULL
surface	NULL
(	NULL
A	NULL
)	NULL
,	NULL
intracellular	NULL
(	NULL
B	NULL
)	NULL
,	NULL
or	NULL
released	NULL
into	NULL
the	NULL
medium	NULL
(	NULL
C	NULL
)	NULL
was	NULL
determined	NULL
.	NULL

Data	NULL
are	NULL
the	NULL
mean	NULL
+	NULL
S.D	NULL
.	NULL

of	NULL
three	NULL
determinations	NULL
.	NULL

The	NULL
precipitated	NULL
material	NULL
was	NULL
resolved	NULL
by	NULL
10	NULL
%	NULL
SDS-polyacrylamide	NULL
electrophoresis	NULL
under	NULL
reducing	NULL
conditions	NULL
,	NULL
transferred	NULL
to	NULL
nitrocellulose	NULL
,	NULL
and	NULL
blocked	NULL
by	NULL
incubation	NULL
with	NULL
5	NULL
%	NULL
nonfat	NULL
dried	NULL
milk	NULL
in	NULL
PBS	NULL
,	NULL
pH	NULL
7.2	NULL
,	NULL
(	NULL
5	NULL
%	NULL
milk	NULL
)	NULL
for	NULL
1	NULL
h.	NULL
The	NULL
nitrocellulose	NULL
was	NULL
subsequently	NULL
incubated	NULL
with	NULL
either	NULL
anti-phospho-STAT5	NULL
(	NULL
Upstate	NULL
Biotechnology	NULL
,	NULL
Lake	NULL
Placid	NULL
,	NULL
NY	NULL
)	NULL
or	NULL
anti-STAT5	NULL
antisera	NULL
in	NULL
5	NULL
%	NULL
milk	NULL
for	NULL
90	NULL
min	NULL
,	NULL
washed	NULL
three	NULL
times	NULL
with	NULL
PBS	NULL
containing	NULL
0.1	NULL
%	NULL
Nonidet	NULL
P-40	NULL
,	NULL
and	NULL
then	NULL
incubated	NULL
with	NULL
horseradish	NULL
peroxidase-conjugated	NULL
donkey	NULL
anti-rabbit	NULL
Ig	NULL
for	NULL
60	NULL
min	NULL
followed	NULL
by	NULL
washing	NULL
twice	NULL
with	NULL
PBS	NULL
containing	NULL
0.1	NULL
%	NULL
Nonidet	NULL
P-40	NULL
and	NULL
once	NULL
with	NULL
PBS	NULL
alone	NULL
.	NULL

Bands	NULL
were	NULL
visualized	NULL
by	NULL
chemiluminescence	NULL
using	NULL
ECL	NULL
Western	NULL
blotting	NULL
detection	NULL
reagents	NULL
(	NULL
Amersham	NULL
Pharmacia	NULL
Biotech	NULL
)	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
instructions	NULL
.	NULL

RESULTS	NULL
Effect	NULL
of	NULL
Proteasome	NULL
Inhibitors	NULL
on	NULL
the	NULL
Internalization	NULL
and	NULL
Degradation	NULL
of	NULL
IL-2-After	NULL
IL-2	NULL
binds	NULL
to	NULL
the	NULL
high	NULL
affinity	NULL
IL-2R	NULL
,	NULL
~50	NULL
%	NULL
is	NULL
detected	NULL
intracellularly	NULL
(	NULL
I/S	NULL
=	NULL
1	NULL
)	NULL
within	NULL
10-15	NULL
min	NULL
(	NULL
8	NULL
,	NULL
4	NULL
)	NULL
,	NULL
and	NULL
a	NULL
similar	NULL
rate	NULL
of	NULL
internalization	NULL
has	NULL
been	NULL
noted	NULL
for	NULL
IL-2R-bearing	NULL
EL4	NULL
,	NULL
including	NULL
1F1yeWT	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
and	NULL
Refs	NULL
.	NULL

6	NULL
and	NULL
13	NULL
)	NULL
.	NULL

By	NULL
45	NULL
min	NULL
,	NULL
~70	NULL
%	NULL
of	NULL
the	NULL
*	NULL
``	NULL
I-labeled	NULL
IL-2	NULL
was	NULL
detected	NULL
intracellularly	NULL
without	NULL
appreciable	NULL
degradation	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
,	NULL
B	NULL
and	NULL
C	NULL
;	NULL
Refs	NULL
.	NULL

6	NULL
and	NULL
13	NULL
)	NULL
.	NULL

To	NULL
test	NULL
whether	NULL
proteasome	NULL
function	NULL
was	NULL
required	NULL
for	NULL
receptor-mediated	NULL
endocytosis	NULL
of	NULL
IL-2	NULL
,	NULL
1F1yeWT	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
*	NULL
``	NULL
I-labeled	NULL
IL-2	NULL
in	NULL
the	NULL
cold	NULL
,	NULL
and	NULL
internalization	NULL
of	NULL
the	NULL
surface-associated	NULL
IL-2	NULL
was	NULL
initiated	NULL
by	NULL
culturing	NULL
the	NULL
cells	NULL
at	NULL
37°C	NULL
in	NULL
the	NULL
absence	NULL
or	NULL
presence	NULL
of	NULL
the	NULL
proteasome	NULL
inhibitor	NULL
MG132	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

During	NULL
the	NULL
first	NULL
10-15	NULL
min	NULL
,	NULL
the	NULL
MG132	NULL
minimally	NULL
affected	NULL
the	NULL
initial	NULL
internalization	NULL
of	NULL
IL-2	NULL
as	NULL
measured	NULL
by	NULL
the	NULL
initial	NULL
loss	NULL
of	NULL
cell	NULL
surface	NULL
IL-2	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
)	NULL
or	NULL
the	NULL
accumulation	NULL
of	NULL
intracellular	NULL
IL-2	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
.	NULL

However	NULL
,	NULL
an	NULL
altered	NULL
I/S	NULL
ratio	NULL
was	NULL
evident	NULL
for	NULL
1F1ycWT	NULL
45	NULL
min	NULL
after	NULL
initiation	NULL
of	NULL
endocytosis	NULL
when	NULL
the	NULL
cells	NULL
were	NULL
cultured	NULL
with	NULL
either	NULL
MG132	NULL
or	NULL
the	NULL
highly	NULL
proteasome	NULL
specific	NULL
inhibitor	NULL
lactacystin	NULL
(	NULL
Fig	NULL
.	NULL

24	NULL
)	NULL
.	NULL

This	NULL
effect	NULL
was	NULL
because	NULL
of	NULL
an	NULL
increased	NULL
level	NULL
of	NULL
surface	NULL
IL-2	NULL
that	NULL
was	NULL
evident	NULL
for	NULL
the	NULL
MG132-treated	NULL
cell	NULL
by	NULL
30	NULL
min	NULL
(	NULL
Fig	NULL
.	NULL

14	NULL
)	NULL
.	NULL

The	NULL
altered	NULL
endocytosis	NULL
by	NULL
MG132	NULL
and	NULL
lactacystin	NULL
was	NULL
specific	NULL
as	NULL
the	NULL
I/S	NULL
ratio	NULL
was	NULL
not	NULL
affected	NULL
when	NULL
1F1ycWT	NULL
were	NULL
treated	NULL
with	NULL
the	NULL
calpain	NULL
inhibitor	NULL
antipain	NULL
or	NULL
the	NULL
cysteine	NULL
protease	NULL
inhibitor	NULL
E-64	NULL
(	NULL
Fig	NULL
.	NULL

24	NULL
)	NULL
.	NULL

After	NULL
60	NULL
min	NULL
in	NULL
culture	NULL
,	NULL
an	NULL
obvious	NULL
fraction	NULL
of	NULL
the	NULL
IL-2	NULL
that	NULL
was	NULL
initially	NULL
associated	NULL
with	NULL
the	NULL
1F1yeWT	NULL
cells	NULL
was	NULL
detected	NULL
in	NULL
the	NULL
culture	NULL
supernatant	NULL
,	NULL
and	NULL
at	NULL
this	NULL
and	NULL
all	NULL
subsequent	NULL
time	NULL
points	NULL
,	NULL
>	NULL
90	NULL
%	NULL
of	NULL
this	NULL
released	NULL
IL-2	NULL
was	NULL
soluble	NULL
in	NULL
trichloroacetic	NULL
acid	NULL
,	NULL
consistent	NULL
with	NULL
its	NULL
degradation	NULL
to	NULL
small	NULL
peptides	NULL
.	NULL

The	NULL
small	NULL
amount	NULL
of	NULL
IL-2	NULL
released	NULL
during	NULL
the	NULL
first	NULL
30	NULL
min	NULL
in	NULL
culture	NULL
was	NULL
precipitated	NULL
by	NULL
trichloroacetic	NULL
acid	NULL
,	NULL
which	NULL
most	NULL
likely	NULL
reflected	NULL
the	NULL
release	NULL
of	NULL
IL-2	NULL
from	NULL
the	NULL
IL-2R	NULL
prior	NULL
to	NULL
its	NULL
endocytosis	NULL
.	NULL

Surprisingly	NULL
,	NULL
MG132	NULL
substantially	NULL
inhibited	NULL
the	NULL
degradation	NULL
of	NULL
IL-2	NULL
(	NULL
Fig	NULL
.	NULL

1C	NULL
)	NULL
.	NULL

Like	NULL
MG132	NULL
,	NULL
the	NULL
related	NULL
peptide	NULL
aldehyde	NULL
proteasome	NULL
inhibitor	NULL
PSI	NULL
,	NULL
but	NULL
not	NULL
antipain	NULL
or	NULL
6-64	NULL
,	NULL
prevented	NULL
the	NULL
degradation	NULL
of	NULL
IL-2	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
.	NULL

This	NULL
finding	NULL
suggests	NULL
that	NULL
the	NULL
inhibition	NULL
by	NULL
these	NULL
two	NULL
peptide	NULL
aldehydes	NULL
is	NULL
caused	NULL
by	NULL
effects	NULL
on	NULL
the	NULL
proteasome	NULL
rather	NULL
than	NULL
effects	NULL
on	NULL
lysosomal	NULL
cysteine	NULL
proteases	NULL
or	NULL
calpains	NULL
.	NULL

Again	NULL
,	NULL
the	NULL
highly	NULL
proteasome-specific	NULL
inhibitors	NULL
lactacystin	NULL
and	NULL
clasto-lactacystin	NULL
B-lactone	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
also	NULL
inhibited	NULL
the	NULL
degradation	NULL
of	NULL
IL-2	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
.	NULL

Dose-response	NULL
studies	NULL
indicated	NULL
that	NULL
2-5	NULL
um	NULL
MG132	NULL
,	NULL
PSI	NULL
,	NULL
or	NULL
lactacystin	NULL
were	NULL
required	NULL
for	NULL
inhibition	NULL
of	NULL
50	NULL
%	NULL
degradation	NULL
of	NULL
IL-2	NULL
(	NULL
Fig	NULL
.	NULL

2C	NULL
)	NULL
.	NULL

This	NULL
concentration	NULL
of	NULL
inhibitors	NULL
is	NULL
consistent	NULL
with	NULL
those	NULL
required	NULL
to	NULL
inhibit	NULL
the	NULL
proteasome	NULL
(	NULL
16-18	NULL
)	NULL
.	NULL

Collectively	NULL
,	NULL
these	NULL
data	NULL
indicate	NULL
that	NULL
proteasome	NULL
function	NULL
is	NULL
necessary	NULL
for	NULL
normal	NULL
receptor-mediated	NULL
endocytosis	NULL
and	NULL
subsequent	NULL
degradation	NULL
of	NULL
IL-2	NULL
.	NULL

Relationship	NULL
Between	NULL
the	NULL
Proteasome	NULL
and	NULL
Lysosome	NULL
for	NULL
Internalization	NULL
and	NULL
Degradation	NULL
of	NULL
IL-2-Previous	NULL
studies	NULL
have	NULL
demonstrated	NULL
that	NULL
upon	NULL
internalization	NULL
of	NULL
the	NULL
IL-2-IL-2R	NULL
complex	NULL
,	NULL
IL-2	NULL
traffics	NULL
to	NULL
the	NULL
lysosome	NULL
and	NULL
is	NULL
degraded	NULL
(	NULL
3	NULL
,	NULL
4	NULL
,	NULL
7	NULL
)	NULL
.	NULL

We	NULL
confirmed	NULL
that	NULL
degradation	NULL
of	NULL
IL-2	NULL
by	NULL
1F1ycWT	NULL
occurred	NULL
in	NULL
the	NULL
lysosome	NULL
as	NULL
its	NULL
degradation	NULL
was	NULL
inhibited	NULL
by	NULL
50	NULL
um	NULL
chloroquine	NULL
(	NULL
Fig	NULL
.	NULL

3A	NULL
)	NULL
.	NULL

The	NULL
peptide	NULL
aldehyde	NULL
proteasome	NULL
inhibitor	NULL
MG132	NULL
was	NULL
even	NULL
a	NULL
somewhat	NULL
more	NULL
potent	NULL
inhibitor	NULL
of	NULL
degradation	NULL
of	NULL
IL-2	NULL
.	NULL

During	NULL
the	NULL
first	NULL
15	NULL
min	NULL
of	NULL
culture	NULL
,	NULL
time-course	NULL
studies	NULL
revealed	NULL
that	NULL
MG132	NULL
only	NULL
minimally	NULL
blocked	NULL
internalization	NULL
of	NULL
IL-2	NULL
(	NULL
Figs	NULL
.	NULL

14	NULL
and	NULL
3B	NULL
)	NULL
.	NULL

However	NULL
,	NULL
after	NULL
a	NULL
20-30	NULL
min	NULL
culture	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
MG132	NULL
,	NULL
internalization	NULL
of	NULL
IL-2	NULL
reached	NULL
a	NULL
maximal	NULL
level	NULL
,	NULL
and	NULL
after	NULL
that	NULL
time	NULL
the	NULL
fraction	NULL
of	NULL
surface	NULL
and	NULL
intracellular	NULL
IL-2	NULL
remained	NULL
constant	NULL
.	NULL

By	NULL
contrast	NULL
,	NULL
chloroquine	NULL
,	NULL
which	NULL
directly	NULL
inhibits	NULL
lysosomal	NULL
function	NULL
,	NULL
showed	NULL
much	NULL
lower	NULL
capacity	NULL
to	NULL
affect	NULL
the	NULL
internalization	NULL
of	NULL
IL-2	NULL
with	NULL
consistently	NULL
a	NULL
higher	NULL
I/S	NULL
ratio	NULL
than	NULL
MG132-treated	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
.	NULL

This	NULL
finding	NULL
in	NULL
conjunction	NULL
with	NULL
the	NULL
complete	NULL
inhibition	NULL
of	NULL
degradation	NULL
of	NULL
IL-2	NULL
by	NULL
proteasome	NULL
and	NULL
lysosome	NULL
inhibitors	NULL
suggests	NULL
that	NULL
impairment	NULL
of	NULL
IL-2	NULL
internalization	NULL
by	NULL
the	NULL
proteasome	NULL
inhibitors	NULL
may	NULL
be	NULL
secondary	NULL
because	NULL
of	NULL
the	NULL
blockade	NULL
in	NULL
trafficking	NULL
of	NULL
IL-2	NULL
to	NULL
the	NULL
lysosome	NULL
,	NULL
preventing	NULL
the	NULL
degradation	NULL
of	NULL
IL-2	NULL
.	NULL

Proteasome	NULL
Function	NULL
Is	NULL
Not	NULL
Required	NULL
for	NULL
Initial	NULL
Internalization	NULL
of	NULL
IL-2-From	NULL
the	NULL
preceding	NULL
data	NULL
,	NULL
only	NULL
the	NULL
initial	NULL
endocytosis	NULL
of	NULL
IL-2	NULL
was	NULL
not	NULL
influenced	NULL
by	NULL
MG132	NULL
.	NULL

However	NULL
,	NULL
this	NULL
apparently	NULL
normal	NULL
internalization	NULL
might	NULL
simply	NULL
be	NULL
related	NULL
to	NULL
a	NULL
short	NULL
delay	NULL
for	NULL
MG132	NULL
to	NULL
effectively	NULL
block	NULL
the	NULL
proteasome	NULL
.	NULL

To	NULL
directly	NULL
test	NULL
whether	NULL
the	NULL
entry	NULL
of	NULL
IL-2	NULL
into	NULL
the	NULL
cells	NULL
was	NULL
unaffected	NULL
by	NULL
proteasome	NULL
inhibitors	NULL
,	NULL
1FlycWT	NULL
cells	NULL
were	NULL
pretreated	NULL
with	NULL
proteasome	NULL
inhibitors	NULL
prior	NULL
to	NULL
initiation	NULL
of	NULL
receptor-mediated	NULL
endocytosis	NULL
(	NULL
Table	NULL
I	NULL
)	NULL
.	NULL

When	NULL
analyzing	NULL
the	NULL
continuous	NULL
internalization	NULL
of	NULL
IL-2	NULL
for	NULL
45	NULL
min	NULL
(	NULL
Table	NULL
I	NULL
,	NULL
Experiment	NULL
1	NULL
)	NULL
,	NULL
the	NULL
fraction	NULL
of	NULL
surface	NULL
and	NULL
intracellular	NULL
IL-2	NULL
was	NULL
comparable	NULL
for	NULL
cells	NULL
pretreated	NULL
with	NULL
either	NULL
the	NULL
Me	NULL
;	NULL
SO	NULL
vehicle	NULL
or	NULL
proteasome	NULL
inhibitors	NULL
.	NULL

In	NULL
the	NULL
latter	NULL
two	NULL
experiments	NULL
(	NULL
Table	NULL
I	NULL
,	NULL
Experiments	NULL
2	NULL
and	NULL
3	NULL
)	NULL
,	NULL
the	NULL
cellular	NULL
distribution	NULL
of	NULL
IL-2	NULL
was	NULL
assessed	NULL
3	NULL
h	NULL
after	NULL
initiation	NULL
of	NULL
endocytosis	NULL
of	NULL
IL-2-pulsed	NULL
cells	NULL
.	NULL

In	NULL
this	NULL
scenario	NULL
,	NULL
most	NULL
of	NULL
the	NULL
cell-associated	NULL
IL-2	NULL
was	NULL
found	NULL
in	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san8	NULL
4g	NULL
/S10-aqf	NULL
/	NULL
wroj	NULL
;	NULL
Proteasome	NULL
and	NULL
Endocytosis	NULL
of	NULL
IL-2	NULL
383	NULL
A	NULL
B	NULL
C	NULL
-	NULL
#	NULL
-	NULL
Lactacystin	NULL
-a-	NULL
MG132	NULL
5	NULL
100	NULL
100-	NULL
-*-	NULL
PSI	NULL
!	NULL

4	NULL
I	NULL
T5	NULL
5	NULL
80	NULL
C	NULL
P3	NULL
w	NULL
3	NULL
£	NULL
=	NULL
60	NULL
Ex	NULL
I	NULL
50	NULL
E	NULL
2	NULL
a	NULL
:	NULL
>	NULL
40	NULL
25	NULL
.	NULL

(	NULL
0	NULL
da	NULL
``	NULL
0	NULL
©	NULL
[	NULL
~	NULL
6	NULL
[	NULL
~	NULL
0	NULL
0	NULL
I~	NULL
E151	NULL
lil	NULL
‘	NULL
GT-	NULL
1	NULL
1	NULL
1	NULL
1	NULL
1	NULL
$	NULL
8	NULL
§	NULL
9	NULL
f	NULL
$	NULL
3	NULL
4	NULL
J	NULL
S8	NULL
f	NULL
0	NULL
10	NULL
20	NULL
30	NULL
40	NULL
50	NULL
2	NULL
4	NULL
&	NULL
0	NULL
$	NULL
2	NULL
u	NULL
g	NULL
b	NULL
$	NULL
E3	NULL
rp	NULL
§	NULL
=	NULL
§	NULL
&	NULL
=	NULL
é	NULL
Inhibitor	NULL
(	NULL
uM	NULL
)	NULL
3	NULL
3	NULL
Fic	NULL
.	NULL

2	NULL
.	NULL

Comparison	NULL
of	NULL
proteasome	NULL
and	NULL
protease	NULL
inhibitors	NULL
on	NULL
the	NULL
internalization	NULL
and	NULL
degradation	NULL
of	NULL
IL-2	NULL
.	NULL

Effect	NULL
on	NULL
internalization	NULL
(	NULL
A	NULL
)	NULL
or	NULL
degradation	NULL
(	NULL
B	NULL
)	NULL
of	NULL
IL-2	NULL
.	NULL

C	NULL
,	NULL
dose-response	NULL
of	NULL
proteasome	NULL
inhibitors	NULL
.	NULL

1F1ycWT	NULL
cells	NULL
were	NULL
pulsed	NULL
with	NULL
**	NULL
``	NULL
I-labeled	NULL
IL-2	NULL
,	NULL
treated	NULL
with	NULL
50	NULL
uM	NULL
indicated	NULL
inhibitors	NULL
as	NULL
described	NULL
under	NULL
``	NULL
Experimental	NULL
Procedures	NULL
,	NULL
``	NULL
and	NULL
cultured	NULL
for	NULL
45	NULL
min	NULL
(	NULL
A	NULL
)	NULL
or	NULL
180	NULL
min	NULL
(	NULL
B	NULL
and	NULL
C	NULL
)	NULL
at	NULL
37	NULL
°C	NULL
.	NULL

In	NULL
A	NULL
,	NULL
the	NULL
fraction	NULL
of	NULL
cell-associated	NULL
IL-2	NULL
that	NULL
was	NULL
intracellular	NULL
(	NULL
F	NULL
)	NULL
versus	NULL
cell	NULL
surface	NULL
(	NULL
S	NULL
)	NULL
was	NULL
determined	NULL
and	NULL
plotted	NULL
as	NULL
the	NULL
I/S	NULL
ratio	NULL
where	NULL
1	NULL
represents	NULL
50	NULL
%	NULL
of	NULL
the	NULL
cell-associated	NULL
IL-2	NULL
within	NULL
an	NULL
intracellular	NULL
compartment	NULL
.	NULL

Data	NULL
in	NULL
A	NULL
are	NULL
the	NULL
and	NULL
range	NULL
of	NULL
two	NULL
independent	NULL
determinations	NULL
,	NULL
except	NULL
for	NULL
lactacystin	NULL
.	NULL

In	NULL
B	NULL
,	NULL
degraded	NULL
IL-2	NULL
was	NULL
assessed	NULL
by	NULL
the	NULL
fraction	NULL
of	NULL
trichloroacetic	NULL
acid-soluble	NULL
cpm	NULL
in	NULL
the	NULL
culture	NULL
medium	NULL
and	NULL
is	NULL
the	NULL
mean	NULL
+	NULL
S.D	NULL
.	NULL

of	NULL
3-6	NULL
determinations	NULL
,	NULL
except	NULL
for	NULL
antipain	NULL
A	NULL
B	NULL
75	NULL
3	NULL
-	NULL
#	NULL
-	NULL
None	NULL
-i-	NULL
MG132	NULL
E	NULL
50	NULL
2	NULL
-*-	NULL
Chloroquine	NULL
©	NULL
#	NULL
a	NULL
a	NULL
F	NULL
o	NULL
s	NULL
25	NULL
1	NULL
0	NULL
5s	NULL
’	NULL
l	NULL
‘	NULL
e	NULL
#	NULL
T	NULL
T	NULL
T	NULL
1	NULL
0	NULL
20	NULL
40	NULL
60	NULL
so	NULL
100	NULL
120	NULL
None	NULL
MG132	NULL
Time	NULL
(	NULL
min	NULL
)	NULL
Chloroquine	NULL
Fic	NULL
.	NULL

3	NULL
.	NULL

Comparison	NULL
of	NULL
proteasome	NULL
and	NULL
lysosome	NULL
inhibitors	NULL
on	NULL
the	NULL
internalization	NULL
and	NULL
degradation	NULL
of	NULL
IL-2	NULL
.	NULL

Effect	NULL
on	NULL
degradation	NULL
(	NULL
A	NULL
)	NULL
and	NULL
internalization	NULL
(	NULL
B	NULL
)	NULL
of	NULL
IL-2	NULL
.	NULL

These	NULL
experiments	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
in	NULL
the	NULL
legend	NULL
to	NULL
Fig	NULL
.	NULL

2	NULL
and	NULL
assayed	NULL
after	NULL
2-8	NULL
h	NULL
(	NULL
A	NULL
)	NULL
or	NULL
the	NULL
indicated	NULL
time	NULL
(	NULL
B	NULL
)	NULL
.	NULL

Data	NULL
in	NULL
A	NULL
represent	NULL
the	NULL
mean	NULL
+	NULL
S.D	NULL
.	NULL

of	NULL
three	NULL
experiments	NULL
and	NULL
B	NULL
is	NULL
representative	NULL
of	NULL
three	NULL
experiments	NULL
.	NULL

TaBLE	NULL
I	NULL
Pretreatment	NULL
of	NULL
1F1ycWT	NULL
with	NULL
proteasome	NULL
inhibitors	NULL
does	NULL
not	NULL
impair	NULL
initial	NULL
internalization	NULL
of	NULL
IL-2	NULL
In	NULL
Experiment	NULL
1	NULL
,	NULL
1F1ycWT	NULL
cells	NULL
were	NULL
pretreated	NULL
with	NULL
MG132	NULL
(	NULL
50	NULL
uM	NULL
)	NULL
for	NULL
60	NULL
min	NULL
at	NULL
87°C	NULL
prior	NULL
to	NULL
adding	NULL
'**I-labeled	NULL
IL-2	NULL
without	NULL
washing	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
further	NULL
cultured	NULL
at	NULL
37	NULL
°C	NULL
for	NULL
45	NULL
min	NULL
,	NULL
and	NULL
cell	NULL
surface-	NULL
and	NULL
intracellular-associated	NULL
cpm	NULL
were	NULL
determined	NULL
.	NULL

In	NULL
experiments	NULL
2	NULL
and	NULL
3	NULL
,	NULL
1F1ycWT	NULL
cells	NULL
were	NULL
pretreated	NULL
with	NULL
PSI	NULL
(	NULL
50	NULL
uM	NULL
)	NULL
or	NULL
lactacystin	NULL
for	NULL
120	NULL
min	NULL
at	NULL
37	NULL
°C	NULL
and	NULL
then	NULL
cooled	NULL
on	NULL
ice	NULL
for	NULL
15	NULL
min	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
then	NULL
pulsed	NULL
with	NULL
***T-labeled	NULL
IL-2	NULL
at	NULL
4	NULL
°C	NULL
for	NULL
30	NULL
min	NULL
.	NULL

After	NULL
washing	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
cultured	NULL
at	NULL
37°C	NULL
for	NULL
180	NULL
min	NULL
with	NULL
further	NULL
addition	NULL
of	NULL
PSI	NULL
or	NULL
lactacystin	NULL
.	NULL

70-85	NULL
%	NULL
of	NULL
the	NULL
cpm	NULL
were	NULL
cell	NULL
surface-associated	NULL
prior	NULL
to	NULL
initiation	NULL
of	NULL
endocytosis	NULL
as	NULL
determined	NULL
by	NULL
cells	NULL
maintained	NULL
at	NULL
4	NULL
°C	NULL
(	NULL
Experiment	NULL
1	NULL
)	NULL
or	NULL
by	NULL
assay	NULL
before	NULL
shifting	NULL
to	NULL
37	NULL
°C	NULL
(	NULL
Experiments	NULL
2	NULL
and	NULL
3	NULL
)	NULL
.	NULL

Experiment	NULL
_	NULL
Inhibitor	NULL
Timzsfsf	NULL
yed	NULL
Surface	NULL
Intracellular	NULL
Degraded	NULL
%	NULL
°IIL-2	NULL
1	NULL
None	NULL
45	NULL
81	NULL
68	NULL
MG-132	NULL
36	NULL
64	NULL
NT	NULL
2	NULL
None	NULL
180	NULL
8	NULL
10	NULL
82	NULL
PSI	NULL
20	NULL
73	NULL
7	NULL
3	NULL
None	NULL
180	NULL
13	NULL
85	NULL
52	NULL
Lactacystin	NULL
180	NULL
25	NULL
62	NULL
11	NULL
*	NULL
NT	NULL
,	NULL
not	NULL
tested	NULL
.	NULL

an	NULL
intracellular	NULL
fraction	NULL
,	NULL
a	NULL
result	NULL
that	NULL
was	NULL
essentially	NULL
identical	NULL
to	NULL
experiments	NULL
where	NULL
the	NULL
proteasome	NULL
inhibitor	NULL
was	NULL
added	NULL
simultaneous	NULL
to	NULL
initiation	NULL
of	NULL
internalization	NULL
.	NULL

Because	NULL
lactacystin	NULL
is	NULL
an	NULL
irreversible	NULL
proteasome	NULL
inhibitor	NULL
,	NULL
the	NULL
accumulation	NULL
of	NULL
intracellular	NULL
IL-2	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
this	NULL
agent	NULL
(	NULL
Table	NULL
I	NULL
,	NULL
Experiment	NULL
3	NULL
)	NULL
strongly	NULL
supports	NULL
the	NULL
notion	NULL
that	NULL
initial	NULL
endocytosis	NULL
of	NULL
IL-2	NULL
was	NULL
unaffected	NULL
by	NULL
blockade	NULL
of	NULL
the	NULL
proteasome	NULL
.	NULL

After	NULL
a	NULL
30-min	NULL
culture	NULL
of	NULL
IL-2-treated	NULL
1Fl1ycWT	NULL
,	NULL
usually	NULL
65-75	NULL
%	NULL
of	NULL
the	NULL
cell-associated	NULL
IL-2	NULL
was	NULL
detected	NULL
as	NULL
an	NULL
intracellular	NULL
fraction	NULL
of	NULL
ligand	NULL
(	NULL
see	NULL
Figs	NULL
.	NULL

1B	NULL
and	NULL
2B	NULL
and	NULL
Ref	NULL
.	NULL

6	NULL
)	NULL
.	NULL

The	NULL
addition	NULL
of	NULL
MG132	NULL
at	NULL
this	NULL
time	NULL
resulted	NULL
in	NULL
inhibition	NULL
of	NULL
degradation	NULL
of	NULL
IL-2	NULL
to	NULL
a	NULL
level	NULL
that	NULL
was	NULL
comparable	NULL
when	NULL
MG132	NULL
was	NULL
added	NULL
at	NULL
the	NULL
initiation	NULL
of	NULL
the	NULL
culture	NULL
(	NULL
Fig	NULL
.	NULL

44	NULL
)	NULL
.	NULL

Substantially	NULL
less	NULL
inhibition	NULL
was	NULL
noted	NULL
when	NULL
MG132	NULL
was	NULL
added	NULL
60	NULL
min	NULL
after	NULL
initiation	NULL
of	NULL
endocytosis	NULL
of	NULL
IL-2	NULL
,	NULL
a	NULL
time	NULL
when	NULL
degradation	NULL
of	NULL
IL-2	NULL
is	NULL
beginning	NULL
to	NULL
be	NULL
detected	NULL
in	NULL
the	NULL
control	NULL
cells	NULL
.	NULL

Furthermore	NULL
,	NULL
when	NULL
compared	NULL
with	NULL
Me	NULL
;	NULL
SO	NULL
vehicle-treated	NULL
cells	NULL
,	NULL
an	NULL
accumulation	NULL
of	NULL
intracellular	NULL
IL-2	NULL
occurred	NULL
when	NULL
MG132	NULL
was	NULL
added	NULL
at	NULL
culture	NULL
initiation	NULL
(	NULL
¢	NULL
,	NULL
)	NULL
or	NULL
30	NULL
min	NULL
later	NULL
.	NULL

The	NULL
increased	NULL
fraction	NULL
of	NULL
intracellular	NULL
IL-2	NULL
was	NULL
most	NULL
prominent	NULL
when	NULL
the	NULL
proteasome	NULL
inhibitor	NULL
was	NULL
delayed	NULL
for	NULL
30	NULL
min	NULL
,	NULL
as	NULL
normal	NULL
levels	NULL
of	NULL
IL-2	NULL
were	NULL
allowed	NULL
to	NULL
first	NULL
be	NULL
internalized	NULL
before	NULL
blocking	NULL
the	NULL
proteasome	NULL
.	NULL

Delayed	NULL
addition	NULL
of	NULL
MG132	NULL
similarly	NULL
affected	NULL
the	NULL
degradation	NULL
of	NULL
**	NULL
``	NULL
I-labeled	NULL
IL-2	NULL
by	NULL
C57BL/6	NULL
T	NULL
blasts	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
)	NULL
,	NULL
demonstrating	NULL
that	NULL
proteasome	NULL
function	NULL
for	NULL
IL-2	NULL
degradation	NULL
was	NULL
not	NULL
unique	NULL
to	NULL
only	NULL
IL-2R-bearing	NULL
EL4	NULL
cells	NULL
,	NULL
but	NULL
was	NULL
also	NULL
required	NULL
for	NULL
a	NULL
normal	NULL
population	NULL
of	NULL
T	NULL
cells	NULL
.	NULL

Collectively	NULL
,	NULL
these	NULL
data	NULL
suggest	NULL
that	NULL
blockade	NULL
of	NULL
the	NULL
proteasome	NULL
inhibits	NULL
a	NULL
relatively	NULL
early	NULL
step	NULL
in	NULL
the	NULL
intracellular	NULL
traffic	NULL
of	NULL
the	NULL
IL-2IL-2R	NULL
complex	NULL
,	NULL
but	NULL
a	NULL
step	NULL
later	NULL
than	NULL
required	NULL
for	NULL
the	NULL
initial	NULL
endocytosis	NULL
of	NULL
the	NULL
receptor-ligand	NULL
complex	NULL
.	NULL

IL-2-induced	NULL
Signaling	NULL
,	NULL
Degradation	NULL
of	NULL
IL-2	NULL
,	NULL
and	NULL
Proteasome	NULL
Function-Normal	NULL
internalization	NULL
of	NULL
IL-2	NULL
is	NULL
dependent	NULL
upon	NULL
the	NULL
cytoplasmic	NULL
tail	NULL
of	NULL
the	NULL
ye-subunit	NULL
of	NULL
the	NULL
IL-2R	NULL
(	NULL
5	NULL
,	NULL
6	NULL
)	NULL
.	NULL

For	NULL
the	NULL
1F1yc284-transfected	NULL
variant	NULL
of	NULL
EL4	NULL
,	NULL
which	NULL
expresses	NULL
wild-type	NULL
IL-2R	NULL
a-	NULL
and	NULL
B-chains	NULL
but	NULL
the	NULL
cytoplasmic	NULL
tailless	NULL
ye-chain	NULL
,	NULL
the	NULL
rate	NULL
of	NULL
internalization	NULL
of	NULL
IL-2	NULL
is	NULL
~2-3-fold	NULL
slower	NULL
than	NULL
1FlycWT	NULL
,	NULL
with	NULL
a	NULL
corresponding	NULL
lower	NULL
fraction	NULL
of	NULL
degraded	NULL
IL-2	NULL
after	NULL
2-3	NULL
h	NULL
in	NULL
culture	NULL
(	NULL
Table	NULL
II	NULL
and	NULL
Ref	NULL
.	NULL

6	NULL
)	NULL
.	NULL

By	NULL
contrast	NULL
,	NULL
the	NULL
CX	NULL
t-transfected	NULL
variant	NULL
of	NULL
EL4	NULL
,	NULL
which	NULL
expresses	NULL
wild-type	NULL
IL-2Ra	NULL
and	NULL
-yc	NULL
,	NULL
but	NULL
a	NULL
cytoplasmic	NULL
tailless	NULL
B-chain	NULL
,	NULL
demonstrated	NULL
essentially	NULL
normal	NULL
rates	NULL
of	NULL
internalization	NULL
and	NULL
degradation	NULL
of	NULL
IL-2	NULL
(	NULL
Ref	NULL
.	NULL

13	NULL
and	NULL
Table	NULL
II	NULL
)	NULL
.	NULL

Importantly	NULL
,	NULL
MG132	NULL
very	NULL
efficiently	NULL
inhibited	NULL
the	NULL
degradation	NULL
of	NULL
the	NULL
fraction	NULL
of	NULL
IL-2	NULL
that	NULL
was	NULL
internalized	NULL
by	NULL
the	NULL
IL-2R	NULL
on	NULL
1F1yc284	NULL
or	NULL
CXt	NULL
(	NULL
Table	NULL
II	NULL
)	NULL
.	NULL

These	NULL
findings	NULL
indicate	NULL
that	NULL
the	NULL
proteasome-dependent	NULL
pathway	NULL
for	NULL
degradation	NULL
of	NULL
IL-2	NULL
is	NULL
independent	NULL
of	NULL
the	NULL
cytoplasmic	NULL
tail	NULL
of	NULL
IL-2RB	NULL
or	NULL
-yc	NULL
,	NULL
including	NULL
the	NULL
respective	NULL
IL-2R-asso-ciated	NULL
signaling	NULL
molecules	NULL
.	NULL

610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san8	NULL
4g	NULL
/S10-aqf	NULL
/	NULL
wroj	NULL
;	NULL
384	NULL
Proteasome	NULL
and	NULL
Endocytosis	NULL
of	NULL
IL-2	NULL
Several	NULL
studies	NULL
have	NULL
implicated	NULL
the	NULL
proteasome	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
Jak-STAT	NULL
signal	NULL
transduction	NULL
,	NULL
including	NULL
IL-2-induced	NULL
activation	NULL
of	NULL
STATS5	NULL
(	NULL
19	NULL
,	NULL
20	NULL
)	NULL
.	NULL

In	NULL
1F1yeWT	NULL
,	NULL
IL-2	NULL
induced	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
STATS	NULL
(	NULL
Fig	NULL
.	NULL

5A	NULL
,	NULL
lane	NULL
1	NULL
versus	NULL
3	NULL
)	NULL
,	NULL
and	NULL
upon	NULL
extended	NULL
culture	NULL
without	NULL
IL-2	NULL
,	NULL
the	NULL
level	NULL
of	NULL
phosphorylated	NULL
STATS5	NULL
was	NULL
considerably	NULL
reduced	NULL
(	NULL
Fig	NULL
.	NULL

5A	NULL
,	NULL
lane	NULL
3	NULL
versus	NULL
5	NULL
and	NULL
7	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
as	NULL
expected	NULL
,	NULL
MG132	NULL
stabilized	NULL
IL-2-induced	NULL
activation	NULL
of	NULL
phosphorylated	NULL
STAT5	NULL
,	NULL
which	NULL
was	NULL
especially	NULL
evident	NULL
after	NULL
2	NULL
h	NULL
in	NULL
culture	NULL
(	NULL
Fig	NULL
.	NULL

5A	NULL
,	NULL
lane	NULL
7	NULL
versus	NULL
8	NULL
)	NULL
.	NULL

To	NULL
investigate	NULL
whether	NULL
this	NULL
enhanced	NULL
signaling	NULL
might	NULL
be	NULL
related	NULL
to	NULL
the	NULL
proteasome-dependent	NULL
blockade	NULL
of	NULL
the	NULL
IL-2	NULL
degradation	NULL
pathway	NULL
,	NULL
we	NULL
examined	NULL
the	NULL
ability	NULL
of	NULL
delayed	NULL
addition	NULL
of	NULL
MG132	NULL
to	NULL
potentiate	NULL
STAT5	NULL
phosphorylation	NULL
in	NULL
1FlyecWT	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
)	NULL
.	NULL

Because	NULL
the	NULL
IL-2	NULL
degradation	NULL
pathway	NULL
was	NULL
nearly	NULL
completely	NULL
inhibited	NULL
even	NULL
when	NULL
MG132	NULL
was	NULL
administered	NULL
30	NULL
min	NULL
after	NULL
initiation	NULL
of	NULL
IL-2-IL-2R	NULL
endocytosis	NULL
,	NULL
we	NULL
reasoned	NULL
that	NULL
the	NULL
stabilized	NULL
phosphorylation	NULL
of	NULL
STAT5	NULL
by	NULL
MG132	NULL
would	NULL
also	NULL
be	NULL
evident	NULL
after	NULL
delayed	NULL
addition	NULL
of	NULL
MG132	NULL
,	NULL
if	NULL
these	NULL
two	NULL
processes	NULL
were	NULL
related	NULL
.	NULL

However	NULL
,	NULL
unlike	NULL
degradation	NULL
of	NULL
IL-2	NULL
,	NULL
MG132	NULL
was	NULL
MG132	NULL
A	NULL
mors	NULL
?	NULL

B	NULL
.	NULL

,	NULL
C-INone	NULL
__	NULL
Ar	NULL
«	NULL
0	NULL
C31	NULL
%	NULL
3	NULL
304	NULL
,	NULL
&	NULL
T	NULL
#	NULL
20	NULL
4	NULL
10	NULL
l	NULL
e	NULL
Surface	NULL
Intracellular	NULL
Degraded	NULL
Surface	NULL
..	NULL
Intracellular	NULL
|	NULL
Degraded	NULL
Fic	NULL
.	NULL

4	NULL
.	NULL

Effect	NULL
of	NULL
delayed	NULL
addition	NULL
of	NULL
MG132	NULL
on	NULL
the	NULL
degradation	NULL
and	NULL
internalization	NULL
of	NULL
IL-2	NULL
.	NULL

1FLycWT	NULL
(	NULL
A	NULL
)	NULL
or	NULL
C57BI/6	NULL
T	NULL
blasts	NULL
(	NULL
B	NULL
)	NULL
were	NULL
pulsed	NULL
with	NULL
**I-labeled	NULL
IL-2	NULL
and	NULL
cultured	NULL
at	NULL
37	NULL
°C	NULL
for	NULL
8	NULL
h.	NULL
MG182	NULL
was	NULL
added	NULL
at	NULL
various	NULL
times	NULL
after	NULL
the	NULL
initiation	NULL
of	NULL
internalization	NULL
by	NULL
culture	NULL
at	NULL
37	NULL
°C	NULL
.	NULL

The	NULL
cpm	NULL
associated	NULL
with	NULL
the	NULL
cell	NULL
surface	NULL
,	NULL
an	NULL
intracellular	NULL
pool	NULL
,	NULL
or	NULL
released	NULL
as	NULL
IL-2	NULL
trichloroacetic	NULL
acid-soluble	NULL
cpm	NULL
in	NULL
the	NULL
supernatant	NULL
were	NULL
determined	NULL
.	NULL

Data	NULL
are	NULL
the	NULL
mean	NULL
and	NULL
range	NULL
of	NULL
two	NULL
independent	NULL
determinations	NULL
.	NULL

TaBLE	NULL
II	NULL
Internalization	NULL
and	NULL
degradation	NULL
of	NULL
IL-2	NULL
by	NULL
IL-2R	NULL
lacking	NULL
the	NULL
cytoplasmic	NULL
tail	NULL
of	NULL
the	NULL
B-	NULL
or	NULL
ye-subunits	NULL
The	NULL
indicated	NULL
cells	NULL
or	NULL
1F1ycWT	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
were	NULL
pulsed	NULL
with	NULL
'*	NULL
``	NULL
I-labeled	NULL
IL-2	NULL
,	NULL
treated	NULL
with	NULL
MG132	NULL
(	NULL
50	NULL
uM	NULL
)	NULL
or	NULL
Me	NULL
;	NULL
SO	NULL
(	NULL
0.5	NULL
%	NULL
)	NULL
,	NULL
and	NULL
cultured	NULL
at	NULL
37	NULL
°C	NULL
for	NULL
3	NULL
hr	NULL
.	NULL

Degraded	NULL
IL-2	NULL
was	NULL
assessed	NULL
by	NULL
the	NULL
fraction	NULL
of	NULL
trichloroacetic	NULL
acid-soluble	NULL
cpm	NULL
in	NULL
the	NULL
culture	NULL
medium	NULL
.	NULL

Degradation	NULL
of	NULL
'*°T-IL-2	NULL
Cells	NULL
Experiment	NULL
%	NULL
control	NULL
``	NULL
%	NULL
inhibited	NULL
by	NULL
MG132®	NULL
1F1yc284	NULL
1	NULL
41.1	NULL
96.1	NULL
2	NULL
42.8	NULL
94.5	NULL
CXBt	NULL
3	NULL
82.5	NULL
75.8	NULL
4	NULL
ND	NULL
96.3	NULL
*	NULL
Comparison	NULL
to	NULL
1FLycWT	NULL
cells	NULL
.	NULL

*	NULL
Comparison	NULL
to	NULL
Me	NULL
,	NULL
SO-treated	NULL
1F1yc284	NULL
(	NULL
Experiments	NULL
1	NULL
&	NULL
2	NULL
)	NULL
or	NULL
CX	NULL
$	NULL
Bt	NULL
(	NULL
Experiments	NULL
3	NULL
and	NULL
4	NULL
)	NULL
.	NULL

*	NULL
ND	NULL
,	NULL
not	NULL
determined	NULL
.	NULL

IL-2	NULL
:	NULL
-	NULL
-o	NULL
t	NULL
4+	NULL
+	NULL
+0	NULL
+	NULL
MG132	NULL
:	NULL
-	NULL
+	NULL
80	NULL
%	NULL
0	NULL
.	NULL

$	NULL
305	NULL
Time	NULL
added	NULL
:	NULL
0	NULL
0	NULL
0	NULL
Time	NULL
assayed	NULL
:	NULL
30	NULL
30	NULL
30	NULL
30	NULL
60	NULL
60	NULL
120	NULL
120	NULL
required	NULL
to	NULL
be	NULL
continuously	NULL
present	NULL
to	NULL
stabilize	NULL
STATS5	NULL
phosphorylation	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
,	NULL
lanes	NULL
3	NULL
and	NULL
4	NULL
versus	NULL
lanes	NULL
5	NULL
and	NULL
6	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
proteasome	NULL
regulation	NULL
of	NULL
IL-2	NULL
signaling	NULL
and	NULL
subsequent	NULL
endocytosis	NULL
appear	NULL
to	NULL
be	NULL
unrelated	NULL
.	NULL

DISCUSSION	NULL
The	NULL
proteasome	NULL
is	NULL
not	NULL
typically	NULL
considered	NULL
as	NULL
a	NULL
key	NULL
regulator	NULL
of	NULL
ligand-induced	NULL
receptor-mediated	NULL
endocytosis	NULL
.	NULL

In	NULL
this	NULL
study	NULL
we	NULL
show	NULL
a	NULL
mandatory	NULL
role	NULL
for	NULL
the	NULL
proteasome	NULL
for	NULL
normal	NULL
endocytosis	NULL
of	NULL
and	NULL
subsequent	NULL
lysosomal	NULL
degradation	NULL
of	NULL
IL-2	NULL
.	NULL

Blockade	NULL
of	NULL
the	NULL
26	NULL
S	NULL
proteasome	NULL
did	NULL
not	NULL
affect	NULL
the	NULL
initial	NULL
endocytosis	NULL
of	NULL
IL-2	NULL
,	NULL
but	NULL
was	NULL
necessary	NULL
for	NULL
sustained	NULL
endocytosis	NULL
and	NULL
was	NULL
essential	NULL
for	NULL
lysosomal	NULL
degradation	NULL
of	NULL
IL-2	NULL
.	NULL

These	NULL
findings	NULL
add	NULL
to	NULL
increasing	NULL
evidence	NULL
that	NULL
rapid	NULL
ligand-induced	NULL
internalization	NULL
of	NULL
cell	NULL
surface	NULL
IL-2-IL-2R	NULL
complexes	NULL
occurs	NULL
by	NULL
a	NULL
novel	NULL
endocytic	NULL
mechanism	NULL
.	NULL

For	NULL
example	NULL
,	NULL
although	NULL
IL-2R	NULL
and	NULL
transferrin	NULL
receptors	NULL
are	NULL
both	NULL
detected	NULL
in	NULL
early	NULL
endosomes	NULL
,	NULL
blockade	NULL
of	NULL
coated-pit	NULL
internalization	NULL
of	NULL
the	NULL
transferrin	NULL
receptor	NULL
had	NULL
minimal	NULL
effect	NULL
on	NULL
the	NULL
internalization	NULL
of	NULL
IL-2-IL-2R	NULL
(	NULL
21	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
these	NULL
molecules	NULL
may	NULL
utilize	NULL
distinct	NULL
pathways	NULL
to	NULL
traffic	NULL
to	NULL
the	NULL
early	NULL
endosome	NULL
.	NULL

Furthermore	NULL
,	NULL
recently	NULL
a	NULL
critical	NULL
endocytic	NULL
signal	NULL
has	NULL
been	NULL
identified	NULL
within	NULL
a	NULL
9-amino	NULL
acid	NULL
sequence	NULL
of	NULL
the	NULL
cytoplasmic	NULL
tail	NULL
of	NULL
yc	NULL
(	NULL
6	NULL
)	NULL
,	NULL
and	NULL
this	NULL
region	NULL
lacks	NULL
tyrosine	NULL
or	NULL
dileucine	NULL
motifs	NULL
that	NULL
target	NULL
receptor-ligand	NULL
complexes	NULL
to	NULL
clathrin-coated	NULL
pits	NULL
,	NULL
which	NULL
are	NULL
typically	NULL
necessary	NULL
for	NULL
entry	NULL
into	NULL
the	NULL
early	NULL
endosome	NULL
compartment	NULL
.	NULL

It	NULL
was	NULL
possible	NULL
to	NULL
delay	NULL
addition	NULL
of	NULL
the	NULL
proteasome	NULL
inhibitor	NULL
MG132	NULL
to	NULL
a	NULL
point	NULL
(	NULL
30	NULL
min	NULL
)	NULL
where	NULL
substantial	NULL
endocytosis	NULL
of	NULL
IL-21IL-2R	NULL
occurred	NULL
and	NULL
still	NULL
potently	NULL
inhibit	NULL
lysosomal	NULL
degradation	NULL
of	NULL
IL-2	NULL
.	NULL

This	NULL
finding	NULL
raises	NULL
the	NULL
possibility	NULL
that	NULL
proteasome	NULL
function	NULL
may	NULL
be	NULL
solely	NULL
required	NULL
for	NULL
trafficking	NULL
internalized	NULL
IL-2	NULL
from	NULL
an	NULL
endosomal	NULL
compartment	NULL
to	NULL
the	NULL
lysosome	NULL
.	NULL

In	NULL
this	NULL
scenario	NULL
the	NULL
capacity	NULL
of	NULL
proteasome	NULL
inhibitors	NULL
to	NULL
impair	NULL
internalization	NULL
of	NULL
IL-2IL-2R	NULL
may	NULL
be	NULL
secondary	NULL
to	NULL
this	NULL
regulatory	NULL
role	NULL
in	NULL
trafficking	NULL
.	NULL

We	NULL
can	NULL
not	NULL
,	NULL
however	NULL
,	NULL
rule	NULL
out	NULL
a	NULL
broader	NULL
role	NULL
for	NULL
proteasome	NULL
function	NULL
for	NULL
endocytosis	NULL
of	NULL
this	NULL
ligand-receptor	NULL
complex	NULL
.	NULL

The	NULL
molecular	NULL
target	NULL
for	NULL
proteasome	NULL
action	NULL
in	NULL
IL-2IL-2R	NULL
endocytosis	NULL
has	NULL
not	NULL
been	NULL
established	NULL
.	NULL

Generally	NULL
,	NULL
polyubiquiti-nation	NULL
of	NULL
intracellular	NULL
proteins	NULL
targets	NULL
them	NULL
for	NULL
recognition	NULL
and	NULL
proteolytic	NULL
degradation	NULL
by	NULL
the	NULL
proteasome	NULL
.	NULL

As	NULL
a	NULL
number	NULL
a	NULL
studies	NULL
have	NULL
demonstrated	NULL
ubiquitination	NULL
of	NULL
cell	NULL
surface	NULL
receptors	NULL
(	NULL
10	NULL
)	NULL
,	NULL
we	NULL
considered	NULL
the	NULL
possibility	NULL
the	NULL
cytoplasmic	NULL
tail	NULL
of	NULL
IL-2R	NULL
B-	NULL
or	NULL
ye-subunits	NULL
might	NULL
be	NULL
critical	NULL
targets	NULL
for	NULL
the	NULL
proteasome	NULL
.	NULL

Importantly	NULL
,	NULL
proteasome	NULL
function	NULL
was	NULL
still	NULL
required	NULL
for	NULL
lysosomal	NULL
degradation	NULL
of	NULL
IL-2	NULL
after	NULL
internalization	NULL
by	NULL
IL-2R	NULL
that	NULL
contained	NULL
cytoplasmic	NULL
tailless	NULL
B-	NULL
or	NULL
ye-subunits	NULL
.	NULL

So	NULL
far	NULL
,	NULL
we	NULL
have	NULL
also	NULL
been	NULL
unsuccessful	NULL
in	NULL
directly	NULL
demonstrating	NULL
that	NULL
these	NULL
subunits	NULL
are	NULL
modified	NULL
by	NULL
ubiquitin	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

POj-STATS	NULL
gogmwee®	NULL
s	NULL
)	NULL
.	NULL
)	NULL

;	NULL
+o	NULL
+	NULL
+o	NULL
O+	NULL
+o	NULL
o+	NULL
A	NULL
+	NULL
+	NULL
+	NULL
+	NULL
0	NULL
0	NULL
30	NULL
60	NULL
30	NULL
120	NULL
30	NULL
120	NULL
120	NULL
120	NULL
Fic	NULL
.	NULL

5	NULL
.	NULL

Effect	NULL
of	NULL
the	NULL
proteasome	NULL
inhibitor	NULL
MG132	NULL
on	NULL
IL-2-induced	NULL
STATS	NULL
activation	NULL
.	NULL

1FLycWT	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
IL-2	NULL
(	NULL
400	NULL
units/ml	NULL
)	NULL
at	NULL
4	NULL
°C	NULL
for	NULL
30	NULL
min	NULL
in	NULL
complete	NULL
medium	NULL
,	NULL
washed	NULL
three	NULL
times	NULL
,	NULL
and	NULL
cultured	NULL
at	NULL
37	NULL
°C	NULL
for	NULL
the	NULL
time	NULL
indicated	NULL
(	NULL
time	NULL
assayed	NULL
)	NULL
.	NULL

MG132	NULL
(	NULL
50	NULL
uM	NULL
)	NULL
or	NULL
Me	NULL
,	NULL
S8O	NULL
(	NULL
0.5	NULL
%	NULL
)	NULL
was	NULL
added	NULL
at	NULL
the	NULL
initiation	NULL
(	NULL
A	NULL
)	NULL
(	NULL
¢	NULL
,	NULL
)	NULL
of	NULL
this	NULL
87	NULL
°C	NULL
culture	NULL
or	NULL
delayed	NULL
(	NULL
B	NULL
)	NULL
,	NULL
as	NULL
indicated	NULL
.	NULL

Nonidet	NULL
P-40	NULL
extracts	NULL
were	NULL
prepared	NULL
from	NULL
these	NULL
cells	NULL
,	NULL
precipitated	NULL
with	NULL
anti-STAT5	NULL
antiserum	NULL
,	NULL
and	NULL
subjected	NULL
to	NULL
Western	NULL
blot	NULL
analysis	NULL
using	NULL
antiserum	NULL
specific	NULL
for	NULL
phosphotyrosine-STATS5	NULL
(	NULL
upper	NULL
panel	NULL
)	NULL
.	NULL

The	NULL
blot	NULL
was	NULL
stripped	NULL
and	NULL
reprobed	NULL
with	NULL
antiserum	NULL
to	NULL
STATS	NULL
protein	NULL
(	NULL
Lower	NULL
panel	NULL
)	NULL
to	NULL
verify	NULL
the	NULL
levels	NULL
of	NULL
STATS	NULL
in	NULL
each	NULL
lane	NULL
.	NULL

Data	NULL
are	NULL
representative	NULL
of	NULL
three	NULL
experiments	NULL
.	NULL

610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san8	NULL
4g	NULL
/S10-aqf	NULL
/	NULL
wroj	NULL
;	NULL
Proteasome	NULL
and	NULL
Endocytosis	NULL
of	NULL
IL-2	NULL
385	NULL
These	NULL
results	NULL
strongly	NULL
suggest	NULL
that	NULL
the	NULL
cytoplasmic	NULL
portion	NULL
of	NULL
the	NULL
IL-2R	NULL
or	NULL
their	NULL
associated	NULL
signaling	NULL
components	NULL
are	NULL
unlikely	NULL
to	NULL
be	NULL
targets	NULL
for	NULL
the	NULL
proteasome	NULL
.	NULL

Consistent	NULL
with	NULL
this	NULL
notion	NULL
,	NULL
we	NULL
showed	NULL
distinct	NULL
kinetic	NULL
requirements	NULL
for	NULL
proteasome	NULL
function	NULL
for	NULL
IL-2-mediated	NULL
endocytosis	NULL
and	NULL
IL-2-induced	NULL
STATS	NULL
tyrosine	NULL
phosphorylation	NULL
.	NULL

A	NULL
number	NULL
of	NULL
cell	NULL
surface	NULL
receptors	NULL
are	NULL
ubiquitinated	NULL
upon	NULL
ligand	NULL
activation	NULL
.	NULL

In	NULL
mammalian	NULL
cells	NULL
,	NULL
the	NULL
platelet-derived	NULL
growth	NULL
factor	NULL
receptor	NULL
(	NULL
22	NULL
)	NULL
,	NULL
growth	NULL
hormone	NULL
receptor	NULL
(	NULL
23	NULL
)	NULL
,	NULL
TCR	NULL
,	NULL
(	NULL
24	NULL
)	NULL
,	NULL
and	NULL
c-kit	NULL
(	NULL
25	NULL
,	NULL
26	NULL
)	NULL
were	NULL
among	NULL
the	NULL
first	NULL
receptors	NULL
shown	NULL
to	NULL
undergo	NULL
ligand-induced	NULL
ubiquitination	NULL
of	NULL
their	NULL
cytoplasmic	NULL
tails	NULL
.	NULL

In	NULL
these	NULL
cases	NULL
,	NULL
the	NULL
lysosome	NULL
appears	NULL
to	NULL
be	NULL
the	NULL
primary	NULL
target	NULL
for	NULL
degradation	NULL
of	NULL
these	NULL
receptors	NULL
.	NULL

In	NULL
Saccha-romyces	NULL
cerevisiae	NULL
the	NULL
G-protein	NULL
coupled	NULL
a-factor	NULL
receptor	NULL
undergoes	NULL
enhanced	NULL
mono-	NULL
or	NULL
short	NULL
chain	NULL
ubiquitination	NULL
upon	NULL
binding	NULL
«	NULL
-factor	NULL
,	NULL
which	NULL
facilitates	NULL
endocytosis	NULL
and	NULL
subsequent	NULL
degradation	NULL
by	NULL
the	NULL
lysosome	NULL
(	NULL
27	NULL
,	NULL
28	NULL
)	NULL
.	NULL

The	NULL
use	NULL
of	NULL
yeast	NULL
defective	NULL
in	NULL
ubiquitin-conjugating	NULL
enzymes	NULL
established	NULL
a	NULL
role	NULL
for	NULL
this	NULL
protein	NULL
modification	NULL
in	NULL
endocytosis	NULL
(	NULL
27	NULL
,	NULL
28	NULL
)	NULL
.	NULL

So	NULL
far	NULL
,	NULL
there	NULL
has	NULL
been	NULL
little	NULL
direct	NULL
evidence	NULL
that	NULL
proteasome	NULL
function	NULL
is	NULL
involved	NULL
in	NULL
this	NULL
process	NULL
,	NULL
and	NULL
it	NULL
has	NULL
been	NULL
suggested	NULL
that	NULL
ubiquitination	NULL
may	NULL
serve	NULL
as	NULL
a	NULL
targeting	NULL
sequence	NULL
for	NULL
entry	NULL
into	NULL
the	NULL
endocytic	NULL
pathway	NULL
leading	NULL
to	NULL
down-regulation	NULL
of	NULL
the	NULL
cell	NULL
surface	NULL
receptor	NULL
(	NULL
10	NULL
)	NULL
.	NULL

One	NULL
exception	NULL
appears	NULL
to	NULL
be	NULL
endocytosis	NULL
of	NULL
the	NULL
growth	NULL
hormone	NULL
receptor	NULL
.	NULL

Similar	NULL
to	NULL
our	NULL
results	NULL
on	NULL
the	NULL
IL-2R	NULL
,	NULL
proteasome	NULL
activity	NULL
appears	NULL
to	NULL
be	NULL
required	NULL
for	NULL
ligand-induced	NULL
endocytosis	NULL
and	NULL
lysosomal	NULL
degradation	NULL
of	NULL
growth	NULL
hormone	NULL
receptor	NULL
that	NULL
is	NULL
independent	NULL
of	NULL
ubiquitination	NULL
of	NULL
the	NULL
cytoplasmic	NULL
tail	NULL
of	NULL
growth	NULL
hormone	NULL
receptor	NULL
(	NULL
29	NULL
)	NULL
.	NULL

The	NULL
fate	NULL
of	NULL
the	NULL
receptor-associated	NULL
ligand	NULL
was	NULL
not	NULL
determined	NULL
in	NULL
that	NULL
study	NULL
.	NULL

Proteasome	NULL
inhibitors	NULL
have	NULL
also	NULL
been	NULL
reported	NULL
to	NULL
affect	NULL
the	NULL
levels	NULL
of	NULL
platelet-derived	NULL
growth	NULL
factor	NULL
receptor	NULL
(	NULL
22	NULL
)	NULL
and	NULL
the	NULL
Met	NULL
kinase	NULL
receptor	NULL
(	NULL
30	NULL
)	NULL
,	NULL
but	NULL
these	NULL
effects	NULL
have	NULL
not	NULL
been	NULL
ascribed	NULL
to	NULL
regulation	NULL
of	NULL
the	NULL
endocytic	NULL
pathway	NULL
.	NULL

If	NULL
our	NULL
findings	NULL
on	NULL
the	NULL
IL-2R	NULL
are	NULL
generalized	NULL
,	NULL
perhaps	NULL
the	NULL
role	NULL
for	NULL
proteasome	NULL
function	NULL
in	NULL
regulating	NULL
these	NULL
cell	NULL
surface	NULL
receptors	NULL
is	NULL
to	NULL
gain	NULL
entry	NULL
into	NULL
a	NULL
cellular	NULL
compartment	NULL
for	NULL
lysosomal/vacuolar	NULL
degradation	NULL
that	NULL
is	NULL
independent	NULL
of	NULL
ubiquitination	NULL
of	NULL
the	NULL
cytoplasmic	NULL
tail	NULL
of	NULL
the	NULL
receptor	NULL
.	NULL

Acknowledgment-We	NULL
thank	NULL
F.	NULL
Olosz	NULL
for	NULL
the	NULL
radiolabeled	NULL
IL-2	NULL
and	NULL
critical	NULL
reading	NULL
of	NULL
this	NULL
manuscript	NULL
.	NULL

REFERENCES	NULL
.	NULL

He	NULL
,	NULL
Y.-W.	NULL
,	NULL
and	NULL
Malek	NULL
,	NULL
T.	NULL
R.	NULL
(	NULL
1998	NULL
)	NULL
Crit	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

18	NULL
,	NULL
508-524	NULL
.	NULL

Nelson	NULL
,	NULL
B.	NULL
H.	NULL
,	NULL
and	NULL
Willerford	NULL
,	NULL
D.	NULL
M.	NULL
(	NULL
1998	NULL
)	NULL
Adv	NULL
.	NULL

Immunol	NULL
.	NULL

70	NULL
,	NULL
1-81	NULL
.	NULL

Duprez	NULL
,	NULL
V.	NULL
,	NULL
Ferrer	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Dautry-Varsat	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

267	NULL
,	NULL
18639-18643	NULL
4	NULL
.	NULL

Weissman	NULL
,	NULL
A.	NULL
,	NULL
Harford	NULL
,	NULL
J.	NULL
,	NULL
Svetlik	NULL
,	NULL
P.	NULL
,	NULL
Leonard	NULL
,	NULL
W.	NULL
,	NULL
Depper	NULL
,	NULL
J.	NULL
,	NULL
Waldmann	NULL
,	NULL
T.	NULL
,	NULL
Greene	NULL
,	NULL
W.	NULL
,	NULL
and	NULL
Klausner	NULL
,	NULL
R.	NULL
(	NULL
1986	NULL
)	NULL
Proc	NULL
.	NULL

Nafl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

88	NULL
,	NULL
1463-1466	NULL
5	NULL
.	NULL

Takeshita	NULL
,	NULL
T.	NULL
,	NULL
Asao	NULL
,	NULL
H.	NULL
,	NULL
Ohtani	NULL
,	NULL
K.	NULL
,	NULL
Ishii	NULL
,	NULL
N.	NULL
,	NULL
Kumaki	NULL
,	NULL
S.	NULL
,	NULL
N.	NULL
,	NULL
T.	NULL
,	NULL
Munakata	NULL
,	NULL
H.	NULL
,	NULL
Nakamura	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Sugamura	NULL
,	NULL
K.	NULL
(	NULL
1992	NULL
)	NULL
Science	NULL
257	NULL
,	NULL
879-382	NULL
to	NULL
bo	NULL
1	NULL
6	NULL
.	NULL

Yu	NULL
,	NULL
A.	NULL
,	NULL
Olosz	NULL
,	NULL
F.	NULL
,	NULL
Choi	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
Malek	NULL
,	NULL
T.	NULL
(	NULL
2000	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

165	NULL
,	NULL
2556-2562	NULL
7	NULL
.	NULL

Hemar	NULL
,	NULL
A.	NULL
,	NULL
Subtil	NULL
,	NULL
A.	NULL
,	NULL
Lieb	NULL
,	NULL
M.	NULL
,	NULL
Morelon	NULL
,	NULL
E.	NULL
,	NULL
and	NULL
Hellio	NULL
,	NULL
R.	NULL
(	NULL
1995	NULL
)	NULL
J	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

129	NULL
,	NULL
55-64	NULL
8	NULL
.	NULL

Coux	NULL
,	NULL
O.	NULL
,	NULL
Tanaka	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Goldberg	NULL
,	NULL
A.	NULL
L.	NULL
(	NULL
1996	NULL
)	NULL
Annu	NULL
.	NULL

Rev	NULL
.	NULL

Biochem	NULL
.	NULL

65	NULL
,	NULL
801-847	NULL
9	NULL
.	NULL

Bonifacino	NULL
,	NULL
J.	NULL
S.	NULL
,	NULL
and	NULL
Weissman	NULL
,	NULL
A.	NULL
M.	NULL
(	NULL
1998	NULL
)	NULL
Annu	NULL
.	NULL

Rev	NULL
.	NULL

Cell	NULL
Dev	NULL
.	NULL

Biol	NULL
.	NULL

14	NULL
,	NULL
19-57	NULL
10	NULL
.	NULL

Hicke	NULL
,	NULL
L.	NULL
(	NULL
1997	NULL
)	NULL
FASEB	NULL
J	NULL
.	NULL

11	NULL
,	NULL
1215-1226	NULL
11	NULL
.	NULL

Strous	NULL
,	NULL
G.	NULL
J.	NULL
,	NULL
and	NULL
Govers	NULL
,	NULL
R.	NULL
(	NULL
1999	NULL
)	NULL
J	NULL
.	NULL

Cell	NULL
Sci	NULL
.	NULL

112	NULL
,	NULL
1417-1423	NULL
12	NULL
.	NULL

He	NULL
,	NULL
Y.-W.	NULL
,	NULL
Adkins	NULL
,	NULL
B.	NULL
,	NULL
Furse	NULL
,	NULL
R.	NULL
K.	NULL
,	NULL
and	NULL
Malek	NULL
,	NULL
T.	NULL
R.	NULL
(	NULL
1995	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

154	NULL
,	NULL
1596-1605	NULL
13	NULL
.	NULL

Furse	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
Malek	NULL
,	NULL
T.	NULL
(	NULL
1998	NULL
)	NULL
Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

28	NULL
,	NULL
3181-3188	NULL
14	NULL
.	NULL

Malek	NULL
,	NULL
T.	NULL
R.	NULL
,	NULL
Porter	NULL
,	NULL
B.	NULL
O.	NULL
,	NULL
Codias	NULL
,	NULL
E.	NULL
K.	NULL
,	NULL
Scibelli	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Yu	NULL
,	NULL
A	NULL
.	NULL

(	NULL
2000	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

164	NULL
,	NULL
2905-2914	NULL
15	NULL
.	NULL

Saragovi	NULL
,	NULL
H.	NULL
,	NULL
and	NULL
Malek	NULL
,	NULL
T.	NULL
(	NULL
1987	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

189	NULL
,	NULL
1918-1926	NULL
16	NULL
.	NULL

Traenckner	NULL
,	NULL
E.	NULL
B.	NULL
,	NULL
Wilk	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Baeuerle	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

13	NULL
,	NULL
5488-5441	NULL
17	NULL
.	NULL

Rock	NULL
,	NULL
K.	NULL
L.	NULL
,	NULL
Gramm	NULL
,	NULL
C.	NULL
,	NULL
Rothstein	NULL
,	NULL
L.	NULL
,	NULL
Clark	NULL
,	NULL
K.	NULL
,	NULL
Stein	NULL
,	NULL
R.	NULL
,	NULL
Dick	NULL
,	NULL
L.	NULL
,	NULL
Hwang	NULL
,	NULL
D.	NULL
,	NULL
and	NULL
Goldberg	NULL
,	NULL
A.	NULL
L.	NULL
(	NULL
1994	NULL
)	NULL
Cell	NULL
78	NULL
,	NULL
761-771	NULL
18	NULL
.	NULL

Fenteany	NULL
,	NULL
G.	NULL
,	NULL
Standaert	NULL
,	NULL
R.	NULL
F.	NULL
,	NULL
Lane	NULL
,	NULL
W.	NULL
S.	NULL
,	NULL
Choi	NULL
,	NULL
S.	NULL
,	NULL
Corey	NULL
,	NULL
E.	NULL
J.	NULL
,	NULL
and	NULL
Schreiber	NULL
,	NULL
S.	NULL
L.	NULL
(	NULL
1995	NULL
)	NULL
Science	NULL
268	NULL
,	NULL
726-731	NULL
19	NULL
.	NULL

Kim	NULL
,	NULL
T.	NULL
K.	NULL
,	NULL
and	NULL
Maniatis	NULL
,	NULL
T.	NULL
(	NULL
1996	NULL
)	NULL
Science	NULL
278	NULL
,	NULL
1717-1719	NULL
20	NULL
.	NULL

Yu	NULL
,	NULL
C.	NULL
L.	NULL
,	NULL
and	NULL
Burakoff	NULL
,	NULL
S.	NULL
J	NULL
.	NULL

(	NULL
1997	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

272	NULL
,	NULL
14017-14020	NULL
21	NULL
.	NULL

Subtil	NULL
,	NULL
A.	NULL
,	NULL
Hemar	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Dautry-Varsat	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
J	NULL
.	NULL

Cell	NULL
Sci	NULL
.	NULL

107	NULL
,	NULL
8461-3468	NULL
22	NULL
.	NULL

Mori	NULL
,	NULL
S.	NULL
,	NULL
Tanaka	NULL
,	NULL
K.	NULL
,	NULL
Omura	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Saito	NULL
,	NULL
Y	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270	NULL
,	NULL
29447-20452	NULL
28	NULL
.	NULL

Strous	NULL
,	NULL
G.	NULL
J.	NULL
,	NULL
van	NULL
Kerkhof	NULL
,	NULL
P.	NULL
,	NULL
Govers	NULL
,	NULL
R.	NULL
,	NULL
Ciechanover	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Schwartz	NULL
,	NULL
A.	NULL
L.	NULL
(	NULL
1996	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

15	NULL
,	NULL
3806-3812	NULL
24	NULL
.	NULL

Cenciarelli	NULL
,	NULL
C.	NULL
,	NULL
Hou	NULL
,	NULL
D.	NULL
,	NULL
Hsu	NULL
,	NULL
K.	NULL
C.	NULL
,	NULL
Rellahan	NULL
,	NULL
B.	NULL
L.	NULL
,	NULL
Wiest	NULL
,	NULL
D.	NULL
L.	NULL
,	NULL
Smith	NULL
,	NULL
H.	NULL
T.	NULL
,	NULL
Fried	NULL
,	NULL
V.	NULL
A.	NULL
,	NULL
and	NULL
Weissman	NULL
,	NULL
A.	NULL
M.	NULL
(	NULL
1992	NULL
)	NULL
Science	NULL
257	NULL
,	NULL
795-797	NULL
25	NULL
.	NULL

Yee	NULL
,	NULL
N.	NULL
S.	NULL
,	NULL
Hsiau	NULL
,	NULL
C.	NULL
W.	NULL
,	NULL
Serve	NULL
,	NULL
H.	NULL
,	NULL
Vosseller	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Besmer	NULL
,	NULL
P.	NULL
(	NULL
1994	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

269	NULL
,	NULL
81991-31998	NULL
26	NULL
.	NULL

Miyazawa	NULL
,	NULL
K.	NULL
,	NULL
Toyama	NULL
,	NULL
K.	NULL
,	NULL
Gotch	NULL
,	NULL
A.	NULL
,	NULL
Hendrie	NULL
,	NULL
P.	NULL
C.	NULL
,	NULL
Mantel	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
Broxmeyer	NULL
,	NULL
H.	NULL
E.	NULL
(	NULL
1994	NULL
)	NULL
Blood	NULL
88	NULL
,	NULL
187-145	NULL
27	NULL
.	NULL

Roth	NULL
,	NULL
A.	NULL
F.	NULL
,	NULL
Sullivan	NULL
,	NULL
D.	NULL
M.	NULL
,	NULL
and	NULL
Davis	NULL
,	NULL
N.	NULL
G.	NULL
(	NULL
1998	NULL
)	NULL
J	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

142	NULL
,	NULL
949-961	NULL
28	NULL
.	NULL

Hicke	NULL
,	NULL
L.	NULL
,	NULL
and	NULL
Riezman	NULL
,	NULL
H.	NULL
(	NULL
1996	NULL
)	NULL
Cell	NULL
84	NULL
,	NULL
277-287	NULL
29.	NULL
van	NULL
Kerkhof	NULL
,	NULL
P.	NULL
,	NULL
Govers	NULL
,	NULL
R.	NULL
,	NULL
Alves	NULL
dos	NULL
Santos	NULL
,	NULL
C.	NULL
M.	NULL
,	NULL
and	NULL
Strous	NULL
,	NULL
G.	NULL
J	NULL
.	NULL

(	NULL
2000	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

275	NULL
,	NULL
1575-1580	NULL
30	NULL
.	NULL

Jeffers	NULL
,	NULL
M.	NULL
,	NULL
Taylor	NULL
,	NULL
G.	NULL
A.	NULL
,	NULL
Weidner	NULL
,	NULL
K.	NULL
M.	NULL
,	NULL
Omura	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Van	NULL
de	NULL
Woude	NULL
,	NULL
G.	NULL
F.	NULL
(	NULL
1997	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

17	NULL
,	NULL
799-808	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san8	NULL
4g	NULL
/S10-aqf	NULL
/	NULL
wroj	NULL
;	NULL
The	NULL
Proteasome	NULL
Regulates	NULL
Receptor-mediated	NULL
Endocytosis	NULL
of	NULL
Interleukin-2	NULL
Aixin	NULL
Yu	NULL
and	NULL
Thomas	NULL
R.	NULL
Malek	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

2001	NULL
,	NULL
276:381-385.	NULL
doi	NULL
:	NULL
10.1074/jbc.MOO7991200	NULL
originally	NULL
published	NULL
online	NULL
October	NULL
13	NULL
,	NULL
2000	NULL
Access	NULL
the	NULL
most	NULL
updated	NULL
version	NULL
of	NULL
this	NULL
article	NULL
at	NULL
doi	NULL
:	NULL
10.1074/jbe.MOO07991200	NULL
Alerts	NULL
:	NULL
«	NULL
When	NULL
this	NULL
article	NULL
is	NULL
cited	NULL
«	NULL
When	NULL
a	NULL
correction	NULL
for	NULL
this	NULL
article	NULL
is	NULL
posted	NULL
Click	NULL
here	NULL
to	NULL
choose	NULL
from	NULL
all	NULL
of	NULL
JBC	NULL
's	NULL
e-mail	NULL
alerts	NULL
This	NULL
article	NULL
cites	NULL
30	NULL
references	NULL
,	NULL
20	NULL
of	NULL
which	NULL
can	NULL
be	NULL
accessed	NULL
free	NULL
at	NULL
http	NULL
:	NULL
//www	NULL
full.html	NULL
#	NULL
ref-list-1	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san8	NULL
4g	NULL
/S10-aqf	NULL
/	NULL
wroj	NULL
;	NULL

